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Kingdom). The work reported in this dissertation resulted from a collaborative effort between the 
Department of Paediatrics and Child Health, Department of Pathology, University of Cape Town, South 
Africa, and the Department of Statistical Sciences, Stellenbosch University, South Africa. 
 
 
The aim of this dissertation was to describe the major components of the gut bacterial profile during the 
first year of life, determine the risk factors influencing that composition and to investigate the association 
between the stool bacteria and the development of recurrent wheezing in infants. The first chapter 
introduces the context of this project as well as some literature. The second chapter presents a 
comprehensive overview of the literature reviewed within the context of this project. The third chapter 
focuses on the experimental and computational approaches used to generate the sequencing data. The 
third chapter also focuses on answering the main aims of the dissertation, detailed above. The work 
described in the third chapter resulted from the following collaborative efforts: 
• The MSc candidate performed the nucleic acid extraction and the library preparation of all the 
faecal samples at the Division of Medical Microbiology, University of Cape Town.  
• The sequencing was performed at the Centre for Proteomic and Genomic Research (CPGR, South 
Africa). Samson Kilaza from the Computational Biology Group, University of Cape Town 
performed the bioinformatics workflow to clean up the raw sequencing data and to classify the 
operational taxonomic units.  
• The data analysis carried out in this was designed by the MSc candidate and Prof. Sugnet Lubbe 
from the Department of Statistical Sciences, Stellenbosch University.  
The fourth and fifth chapters are the general discussion and general conclusion respectively. These tie in 
together the different elements of this dissertation. The submitted material is the work of the MSc 
candidate, unless stated otherwise by acknowledgments. 
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Abstract 
 
Background: Wheezing is one of the leading respiratory symptoms in childhood, which with 
recurrent occurrence can lead to asthma at school age. Few studies, with conflicting findings, 
have investigated the contribution of stool bacteria in childhood wheezing illness. Additionally, 
most of the published studies were conducted in high-income countries using small sample sizes 
and targeted bacterial detection techniques. To address these limitations, we conducted this study 
to determine the association of the infant stool bacterial diversity and composition with wheezing 
development.   
Methods: We conducted a longitudinal case-control study nested within the Drakenstein Child 
Health Study, Western Cape, South Africa. We included 140 infants with wheeze (cases) and 
140 age-matched controls. Passed faecal samples were collected from infants at birth, whilst 
aspirated or passed faecal samples were collected at six weeks, six months and 12 months. 
Deoxyribonucleic acid (DNA) was extracted from all the samples using the manual ZR Fecal 
DNA MiniPrep™ Kit. Sequencing of the hypervariable V4 region of the 16S rRNA gene was 
performed using the Illumina MiSeq technique. The resulting sequencing data was subjected to 
bioinformatic quality control checks and statistical analysis.  
Results: One of the main findings from the systematic review of wheezing data was the observed 
association between the development of atopic wheezing and four bacteria namely 
Faecalibacterium, Lachnospira, Veillonella and Rothia. This study included 280 children 
(n=123 female and n=157 male) recruited from TC Newman (38.5%) and Mbekweni (61.5%) 
areas. Stool samples were collected from 159 infants at birth, 114 infants at six weeks, 141 
infants at six months and 98 infants at 12 months of age. Aspirate and passed stool samples were 
found to be similar and comparable in terms of the bacterial composition. At age six weeks, 16% 
(23/140) of the infants included had wheezed once. During the first year, the proportion of infants 
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with recurrent wheezing (≥ 2 wheezing episodes) was 56% (78/140). Independent factors 
influencing the composition and diversity of the infants faecal bacteria were feeding practices, 
age of mothers and living conditions (all p<0.05). We did not observe distinct faecal bacterial 
profiles between infants with and without wheeze at any taxonomic level analysis (all p>0.05). 
In addition, we did not find significant difference between infants with and without wheeze for 
selected bacteria reported to be associated with wheezing. However, we observed an increased 
relative abundance of Proteobacteria at 12 months of age in infants who had previously 
wheezed. Additionally, Lactobacillales was in apparently significantly higher proportions in 
recurrent wheezers as compared to infants who wheezed once (p<0.05).  
Conclusion: This study shows that aspirated stool is a good alternative for passed stool in 
microbiome studies. Furthermore, it revealed the complex and dynamic nature of the faecal 
bacteria, as well as factors influencing the faecal bacterial profile during the first year of life. 
More studies in this cohort, including the use of metagenomic and metabolomic approaches are 
required to demonstrate the role played by bacterial types and their metabolites in the 
development of wheezing illness. Finally, because recurrent wheezing is one of the precursors 
of asthma, there is a need for an additional follow-up of these infants in order to investigate the 
contribution of the early faecal microbiome in the development of asthma at school age. 
 3 
Chapter 1 - General Introduction 
 4 
1.1. Background and rationale  
 
Wheezing illness is one of the major causes of respiratory morbidity and decreased lung function 
during the first year of life  (Panettieri et al., 2008; Fauroux et al., 2014; Moraes et al., 2014). 
The global prevalence of recurrent wheezing in infants during the first 12 months is about 20% 
(Nriagu et al., 1999; Sunyer et al., 2001; Smuts et al., 2011). Consequences of early wheeze 
include hospitalizations, reduced quality of life as well as increased chances of developing 
recurrent wheezing and asthma later on in life (Kotaniemi-Syrjanen et al., 2003; Arden et al., 
2006; Henderson et al., 2008). Recurrent wheezing is not only an early indication of possible 
childhood asthma, but it also has significant health impacts on young children (Sigurs and Bj, 
2000; Acevedo et al., 2012; Ducharme, Tse and Chauhan, 2014). Infant wheezing can be 
triggered by a variety of factors, some of which include bacterial and viral infections, genetic 
predisposition and dysbiosis of the lung and gut microbiome (Oddy et al., 2004; Kusel et al., 
2007; Yao et al., 2011; Arrieta et al., 2015; Kwong and Bacharier, 2017; Ta et al., 2018). 
 
At present, many research groups have been focusing on the role played by the gut microbiome 
in the development of infant wheezing (Van Nimwegen et al., 2011; Gosalbes et al., 2013; 
Arrieta et al., 2015). Previous studies have also observed that the gut microbiome is a key player 
in the development of the infant immune system (Sharma et al., 2009; Gritz and Bhandari, 2015). 
These studies also noted that a dysbiosis of the gut microbiome could result in a weaker immune 
system. Previous epidemiological studies have observed an association between infant wheezing 
illness and faecal bacteria (Murray, Tannock, Simon, Harmsen, Welling and Custovic, 2005; 
Penders et al., 2007; Van Nimwegen et al., 2011; Arrieta et al., 2015). Arrieta and colleagues 
observed that children with recurrent wheezing and at risk of developing asthma had significantly 
reduced amounts of the genera Faecalibacterium, Lachnospira, Veillionella and Rothia (Arrieta 
et al., 2015). Nambu and colleagues reported that if the infants were colonised with Bacteroides 
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at four months of age, they were likely to develop allergy at one year (Nambu, Shintaku and 
Ohta, 2004). Gut colonisation with Clostridium difficile has been associated with a higher risk 
of developing recurrent wheezing (Penders et al., 2007, 2008; Van Nimwegen et al., 2011).  
 
Nevertheless, the results from previous studies investigating the association between developing 
wheezing in infancy and the faecal bacteria have been inconsistent. We speculate that these 
inconsistencies could be due to differences in sample sizes, definitions of recurrent wheezing 
and experiment analyses carried out (Nambu et al., 2004; Murray et al., 2005; Amberbir et al., 
2011; Bisgaard et al., 2011; Arrieta et al., 2015).  Furthermore, limited studies focusing on the 
association between faecal bacteria and wheezing illness have been conducted in developing 
countries. Therefore, large-scale longitudinal birth cohort studies in developing countries, using 
high-throughput sequencing of the 16S rRNA gene, are needed to provide a community-wide 
taxonomic assessment of the faecal bacteria and its role in wheezing illness.  
 
1.2. Study hypothesis and aim 
 
The main objective of this Masters project was to investigate the association between the 
composition of the infant stool bacteria and the development of recurrent wheezing in infants.  
 
1.3. Dissertation outline 
 
This dissertation begins with a systematic review that focuses on the association between 
gastrointestinal bacteria and the development of infant wheezing. The systematic review 
included a comprehensive view of the literature available from different regions on this topic up 
to a particular date. The following chapter then details the experimental flow and the main 
findings observed in this study. This chapter also reported on the infant bacterial profiles in the 
first year of life, the risk factors associated with bacterial acquisition and the association between 
 
  
6 
the infant stool bacteria and wheezing illness. The experimental findings chapter is succeeded 
by a general discussion and conclusion. 
  
 
 7 
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Chapter 2 – A Systematic Review of the 
Association of Gastrointestinal Bacteria with the 
Development of Wheeze in Young Children
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2.1. Abstract 
Background: There is no comprehensive assessment of published articles on the contribution of 
faecal bacteria in the development of childhood wheezing illness. This systematic review aimed 
to address this issue. 
Methods: A set of keywords were used to search in four electronic databases (Medline, Scopus, 
EBSCOhost, and Web of Science) for studies reporting on faecal bacteria and wheezing. 
Additional articles missed by our search terms strategy were obtained by reading references cited 
in the eligible studies. The search and selection of eligible studies was conducted by two 
independent authors. The last literature search was carried out on 19 August 2017. 
Results: We included 9 studies conducted in children under five years old, all reporting on 
wheezing, but with 78% (7/9) of them assessing for recurrent wheezing as an outcome.  Most of 
the studies (89%; 8/9) were cross-sectional, and the median sample size of the included studies 
was 319 participants (range: 18 - 957). Most of the included studies used culture-independent 
techniques (67%, 6/9) to characterize the faecal bacteria, and massively parallel 16S rRNA gene 
sequencing was performed in only two of these studies. The majority of the eligible studies (67%, 
6/9) were conducted in Europe [Belgium (n= 1), Netherlands (n= 3), Spain (n= 1), and United 
Kingdom (n= 1)]. The remaining three studies were conducted in North America [Canada (n= 
1)], Asia [Japan (n= 1)] and Africa [Ethiopia (n= 1)]. The detection of Bifidobacteria spp. (n= 1 
study; OR = 3.65; 95% CI: 1.21 to 11.0) was significantly associated with an increased risk for 
wheezing. The detection of Clostridium difficile (n= 3 studies) was significantly associated with 
wheezing. In contrast, a single study reported a decreased risk for wheezing (OR = 0.53; 95 % 
CI 0.30 to 0.92) associated with the genus Clostridium.  The protective role of FLVR bacteria 
(Faecalibacterium, Lachnospira, Veillonella and Rothia) was reported in Canadian children with 
atopic wheeze at the age 1 year. 
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Conclusion: Very few studies based on small sample sizes reported significant associations 
between wheezing illness and faecal bacteria. These findings are of great interest because 
recurrent wheezing is an important predictor of asthma later in life. Therefore, larger longitudinal 
birth cohort studies are warranted to study the contribution of faecal bacteria in recurrent 
wheezing. In addition, these studies should adopt high-throughput sequencing techniques (16S 
rRNA gene and/or whole genome shotgun sequencing) or high-throughput bacterial culture 
systems (culturomics) as methods of choice, to determine the faecal bacterial profiles of 
wheezing children.  
 
2.2. Introduction  
 
Wheezing is defined as a high-pitched whistling sound made while breathing, that usually affects 
children under the age of five years (Martinez et al., 1995; Lau et al., 2003; Taussig et al., 2003). 
It is diagnosed based on history of wheeze reported by parents/guardians and/or symptoms 
evidenced by the physicians (Nambu, Shintaku and Ohta, 2004; Murray, Tannock, Simon, 
Harmsen, Welling and Custovic, 2005a; Van Nimwegen et al., 2011). The definitions of 
recurrent wheezing are inconsistent between researchers (Murray, Tannock, Simon, Harmsen, 
Welling and Custovic, 2005b; Penders, Thijs, P. a van den Brandt, et al., 2007; Arrieta et al., 
2015), but it is usually defined as three or more wheezing episodes within 12 months (Murray, 
Tannock, Simon, Harmsen, Welling, Custovic, et al. 2005; John Penders, Thijs, van den Brandt, 
Kummeling, Snijders, Stelma, Adams, van Ree, Stobberingh, et al. 2007).  
 
Wheezing episodes in children are often caused by viral and bacterial infections (Ferguson, 
Whitelaw and Brown, 1992; Martinez et al., 1995; Johnston et al., 1996; Oddy et al., 2004; 
Arden et al., 2006; Kusel et al., 2007; De Schutter et al., 2012; Jackson et al., 2012). Wheezing 
typically starts in the first year of life and significantly affects the quality of life of both concerned 
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infants and their parents/legal guardians (Ungar and Coyte, 2001; Stevens et al., 2003). In 
addition, it is usually accompanied with multiple pediatric health care facility visits, some of 
which can lead to hospitalizations (Kotaniemi-Syrjanen et al., 2003; Arden et al., 2006; 
Henderson et al., 2008). It is estimated that one in every three infants has wheezed at some point 
in their childhood (Bisgaard and Szefler, 2007). Furthermore, infants who wheezed early in life 
are more likely to develop recurrent wheezing, one of the risk factors of asthma later in life (Ly 
et al., 2006; Sigurs et al., 2010; Neuman et al., 2014).  
 
There are numerous risk factors reported in literature that have been associated with the 
development of wheezing in infancy. Some of the risk factors as determined by meta-analyses 
are preterm birth, low birth weight, antibiotic exposure in pregnancy and rhinovirus-induced 
wheezing (Been et al., 2014; Mebrahtu et al., 2015; Zhao et al., 2015; Liu et al., 2017). Meta-
analyses and reviews on the role of breastfeeding in infant wheezing have concluded that 
breastfed infants have lower incidences of wheezing than formula fed infants (Friedman and 
Zeiger, 2005; Ip et al., 2007; Lodge et al., 2015). Air pollution, which includes maternal smoking 
and traffic related smoke have also been shown to be associated with wheezing illness in infants 
(Esposito et al., 2014; Vanker, Gie and Zar, 2018). In addition, the human (lung and gut) 
microbiome has been associated with the development of childhood wheezing illness (Arrieta et 
al., 2015; Kwong and Bacharier, 2017; Rosas-Salazar et al., 2018; Ta et al., 2018). Exposure to 
a specific bacterium or group of bacteria has been associated with either a protective (Arrieta et 
al., 2015) or non-protective role (Verhulst et al., 2008) of gastrointestinal microbes in wheezing 
development. The conflicting reports on the contribution of certain faecal bacterial species in the 
development of childhood wheezing illness and the lack of a comprehensive literature review on 
this topic led us to write this review. This systematic review aimed to assess the association 
between the gastrointestinal bacteria and the development of wheezing illness in young children.  
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2.3. Methodology  
 
2.3.1. Literature search strategy 
 
We systematically searched through four electronic databases (Medline, Scopus, EBSCOhost, 
and Web of Science) for peer-reviewed articles reporting on the detection of bacteria in faeces 
of infants with wheezing (Table 2.1). We assessed for eligibility in all articles published in 
English up until 19 August 2017. To identify additional articles missed by our search strategy, 
we cross-checked reference lists of all the studies included in this systematic review.     
2.3.2. Selection of eligible studies 
 
To select eligible studies (Figure 2.1), we followed the preferred reporting items for systematic 
reviews and meta-analyses (PRISMA) guidelines (Moher et al., 2009). Based on titles and 
abstracts, all records identified through the keyword search were assessed by two independent 
authors. Full text articles of studies selected as potentially relevant were thoroughly and 
independently assessed by two authors for final inclusion according to the listed criteria in Table 
2.2.   
 
2.3.3. Data extraction from each eligible study 
 
Two authors independently performed data extraction from each eligible article using a 
standardized data extraction form. Any inconsistencies or disagreements between the two main 
reviewers were resolved by consensus, with a third reviewer requested to arbitrate on unresolved 
disagreements. We extracted the following information from each eligible study: country where 
the study was conducted, study type, age at which specimens were collected, duration of follow-
up, methods used to define wheeze outcome, number of participants positive for wheeze, 
techniques used to detect faecal bacteria, faecal bacteria detected and odds ratio for the specific 
bacteria detected that were associated with wheezing illness (Table 2.3, 2.4).  
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2.3.4. Data analysis and synthesis 
 
We performed narrative synthesis of included studies according to the research objectives and 
presented data in tables or figures. This included reporting on the total number of eligible studies, 
the main characteristics of the studies, data on the association between the faecal bacteria and 
the development of wheezing and recurrent wheezing, the factors affecting wheezing and the 
bacterial composition of faeces. We reported on the prevalence of specific bacteria, where 
appropriate.
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Table 2.1. Search strategy performed in four electronic databases. 
Database   Search mode   Keywords 
Medline via PubMed   All fields  
(microbiomic OR viromic OR microbiomics OR viromics OR 
microflora OR microbiome OR microbiota OR microbiomes OR 
microbiotas OR “human microbiotas” OR “human microbiomes” OR 
“gastrointestinal microbiome” OR “gut microbiotas” OR “gut 
microbiomes” OR “intestinal flora” OR “intestinal microflora” OR 
“digestive flora” OR “gut flora” OR metagenome OR metagenomic 
OR virome OR mycobiome OR mycobiomes OR mycobiota OR 
mycobiotas OR "fungal microbiome" OR “fungal microbiomes” OR 
“fungal microbiota” OR “fungal microbiotas”)  
AND  
(feces OR stool OR faeces OR faecal OR fecal)  
AND  
(“respiratory sounds” OR “respiratory sound”  OR “lung sounds” OR 
“lung sound” OR wheez* OR asthma* OR “bronchial asthma” OR  
“asthma predictive index”) 
Academic Search Premier, Africa-
Wide Information and CINAHL via 
EBSCOHost 
  Boolean/Phrase  
Web of Science via Web of 
Knowledge   Topic 
 
Scopus via SciVerse   Article title, abstract, keywords   
 
Table 2.2. Eligibility criteria for the systematic review. 
Inclusion criteria Exclusion criteria 
• Studies published through 19 August 2017 
• Microbiological studies using faecal specimens 
• Cohort, cross-sectional or case-control studies 
• Studies carried out in infants 
 
• Microbiological assessment of specimens other than faeces 
• Studies not reporting on wheeze 
• Assessment of the effect of antibiotic, pre- or probiotic treatment 
• Review articles, editorials, commentaries, or experimental studies  
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2.4. Results  
 
2.4.1. Study selection 
 
We identified 3688 articles from four electronic databases (Figure 2.1). Following the review of 
the titles and abstracts of the 3568 unduplicated articles from electronic databases, 3548 articles 
were excluded. Of the remaining 20 articles for which full-text readings were performed, only 9 
articles fulfilled our inclusion criteria (Figure 2.1).  
 
 
 
 
Figure 2.1. Flow diagram of systematic review process using the Preferred Reporting Items for Systematic 
Review and Meta-Analyses (PRISMA) guidelines. 
 
 
2.4.2. Eligible microbiota studies that reported on single wheeze episode 
 
2.4.2.1. Characteristics of studies  
 
Table 2.3 summarizes the main characteristics of the 2 studies included in this systematic review 
that reported on the development of single wheezing episode only, and did not document 
recurrent wheezing. One of the studies was a prospective birth cohort whilst the other was just a 
prospective cohort study. The Japanese study reported on faecal microbial profiles of the infants 
3688 records identified through database searching:
• EBSCO = 45
• PubMed = 67
• Scopus = 3469
• Web of Science = 107 2 additional records identified from cited literature
3568 records included after removing duplicates 
3568 records screened based on titles and abstracts
3548 records excluded for the reasons below:
• Animal studies
• Not Microbiome studies
20 full-text articles assessed for eligibility
11 full-text articles excluded, with reasons:
• Not Microbiome studies
• No infant stool
• Not full study, protocol only
• Review
• Intervention studies
9 studies included in qualitative synthesis
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at 4 months whilst the Ethiopian study was at 3 years of age. The Japanese study was carried out 
in 2004 whilst the Ethiopian study was in 2011. Between the two studies, the wheezing definition 
was either based on doctors’ assessment or parental reports. The Ethiopian and Japanese studies 
recorded the wheezing diagnosis at ages of three years and one year respectively (Figure 2.3). 
Faecal bacteria profiles of the two studies were characterized by culture-dependent techniques. 
None of the included studies reported on the use of either prebiotics or probiotics. None of the 
two studies on wheezing only demonstrated causal evidence for wheezing development. 
Amberbir and colleagues observed that the use of paracetamol and antibiotics in the child were 
significantly associated with wheezing (Amberbir et al., 2011).  
 
2.4.2.2.  Association between the faecal bacteria and wheezing illness 
 
The main focus of this review was the association between faecal bacteria and wheezing illness. 
The two studies that reported on single wheeze episodes did not find any significant association 
between the wheezing outcome and the faecal bacteria. Amberbir and colleagues investigated 
the association between wheezing and Enterococci, Lactobacilli and Bifidobacteria, but none 
were significantly associated (Amberbir et al., 2011). Nambu and colleagues did not report on 
the odds ratio (OR), and did not observe any significant associations between the faecal bacteria 
and wheezing illness in infants (Nambu, Shintaku and Ohta, 2004). 
 
2.4.3. Eligible microbiota studies that reported on recurrent wheezing 
2.4.3.1. Characteristics of studies and risk factors affecting the development of wheezing  
 
Table 2.4 summarizes the main characteristics of the 7 studies included in this systematic review. 
All of these 7 studies reported on recurrent wheezing, a subset of these studies also documented 
single wheezing episodes as well (Verhulst et al., 2008; Van Nimwegen et al., 2011; Gosalbes 
et al., 2013; Arrieta et al., 2015). All the studies reported were prospective birth cohort studies 
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and reported on faecal microbial profiles of the infants at different ages ranging from birth to 3 
years. One of the studies included in this review looked at the faecal microbial profile at two 
separate time points in the same participants. Most of the eligible studies were conducted in 
Europe (86%, 6/7), between 2005 and 2013. Wheezing illness definition was heterogeneous and 
its diagnosis was based on doctors’ assessment or parental reports. Most of the studies (67%) 
included in this review were collected in the first three months of life (Figure 2.2). Faecal 
bacterial screening in children less than five months was performed in 86% (6/7) of the studies. 
Faecal bacteria profiles were characterized by culture-dependent techniques in 14% (1/7) of the 
eligible studies. Culture-independent techniques used included quantitative real-time polymerase 
chain reaction (qPCR) (43%; 3/7), denaturing gradient gel electrophoresis (DGGE) in 
combination with PCR (14%; 1/7) (Murray, Tannock, Simon, Harmsen, Welling, Custovic, et 
al., 2005), fluorescent in-situ hybridization (FISH) (14% ; 1/7) and massively parallel generation 
sequencing of 16S rRNA genes (29%; 2/7). None of the included studies reported on the use of 
either prebiotics or probiotics. Of the seven studies on recurrent wheezing only one (14%) 
demonstrated causal evidence for wheezing development. The study by Verhulst and colleagues 
observed a trend indicating the protective effect of breastfeeding on wheezing development 
(OR=0.54: 95% CI: 0.28 to 1.07) p=0.07, while the use of antibiotics and having male gender 
was associated with increased risk of wheezing. The study by Murray and colleagues recorded 
wheezing at the age of three years (Murray, 2005). 
 
2.4.3.2. Association between the faecal bacteria and wheezing illness 
 
Of the recurrent wheezing studies included in this review, 71% (5/7) of them reported the 
bacterial species that were significantly associated with the development of wheezing (Table 
2.4). The remaining 29% of studies did not observe any significant associations between the 
bacteria and the development of wheezing. Arrieta and colleagues observed that four bacterial 
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genera (FLVR) were significantly reduced in the gut bacteria of wheezing infants, though they 
did not report the OR (Arrieta et al., 2015). To prove causation, they investigated the impact of 
these four genera in a murine model of airway inflammation using a human faecal microbiota; 
some were supplemented with FLVR bacteria and others were not. Mice born to the parents 
supplemented with FLVR perpetuated the strains and exhibited reduced lung inflammation when 
compared to those without (Arrieta et al., 2015). Colonization with Bifidobacteria and anaerobic 
bacteria at three weeks of age was associated with an increased risk of wheezing during the first 
year of life (OR = 3.65; 95% CI 1.21 to 11.0) and (OR = 1.14; 95% CI 1.02 to 1.28) respectively 
(Verhulst et al., 2008). Some of the studies included did not observe any association between 
Bifidobacterium and wheezing (Murray, Tannock, Simon, Harmsen, Welling and Custovic, 
2005a; Penders, Thijs, P. a van den Brandt, et al., 2007; Amberbir et al., 2011; Van Nimwegen 
et al., 2011; Arrieta et al., 2015). Verhulst and colleagues also observed that colonization with 
Staphylococcus was significantly associated with a decreased risk for wheezing (OR= 0.95; 95% 
CI 0.90 to 1.00) p=0.048 (Verhulst et al., 2008). Conflicting data was also found in the studies 
included in this review. A study by a groups of researchers reported the taxon Clostridium as 
protective against wheezing (Verhulst et al., 2008). However, three other studies suggested that 
the taxon Clostridium had more of a causative role in relation to wheezing in infancy (Penders, 
Thijs, P. A. van den Brandt, et al., 2007; Penders et al., 2008; Van Nimwegen et al., 2011). The 
study by Verhulst and colleagues reported that colonization with the genus Clostridia at three 
weeks of life was significantly associated with a decreased risk for wheezing during the first year 
of life (OR= 0.53; 95% CI 0.30 to 0.92) (Verhulst et al., 2008). However, three of the included 
studies reported that infants colonized with Clostridium difficile had a significantly increased 
risk of wheezing (43%, 3/7) (Penders, Thijs, P. a van den Brandt, et al., 2007; Penders et al., 
2008; Van Nimwegen et al., 2011). The Canadian study reported significant reductions in the 
presence of four bacterial genera (Faecalibacterium, Lachnospira, Vellionella and Rothia) 
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termed FLVR, in the faecal matter of the atopic wheezing children, but these same differences 
were not observed in wheezing only children (Arrieta et al., 2015). The study by Arrieta and 
colleagues also confirmed that early microbial profile (3 months) is more suited to predicting 
wheezing later on in life, than the microbial profile at one year (Arrieta et al., 2015). 
 
 
 
 
Figure 2.2. Age at which faecal samples were collected in all the nine studies under investigation. 
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Table 2.3. Characteristics and main findings of studies analyzing the association between faecal bacteria and the development of wheezing. 
Country Study 
design 
Age at which 
specimens 
were 
collected 
Age at which 
participants 
were followed up 
for wheeze 
Wheeze diagnosis Participants 
with wheeze 
% (n/N) 
Techniques 
used to detect 
bacteria 
Faecal bacteria detected Risk associated with wheeze development Citation 
OR (95% CI) Cases Controls 
Ethiopia Prospective 
birth cohort 
3 years 2-3 years ISAAC 
questionnaires 
completed by 
parents 
9.1 (80/876) Culture-based Enterococci 
Lactobacilli 
Bifidobacteria 
1.27 (0.72 - 2.24) 
1.19 (0.66 - 2.16) 
1.24 (0.63 - 2.47) 
NR 
NR 
NR 
NR 
NR 
NR 
Amberbir et 
al., 2011 
Antigen test Helicobacter pylori 0.80 (0.46 - 1.38) NR 
 
NR 
 
Japan Prospective 
cohort 
4 months 1 year Doctor diagnosed 
wheezing 
16.7 (3/18) Culture-based Lactobacilli 
Bifidobacteria  
Clostridia 
NR 
NR 
NR 
NR 
NR 
NR  
NR 
NR 
NR  
Nambu et al., 
2004 
 
 
Table 2.4. Characteristics and main findings of studies analyzing the association between faecal bacteria and the development of recurrent wheezing. 
Country Study type Age at which 
specimens 
were 
collected 
Age at which 
participants were 
followed up for 
wheeze 
Wheeze diagnosis Participants 
positive for 
wheeze: 
% (n/N) 
Techniques 
used to detect 
bacteria 
Faecal bacteria detected Risk associated with wheeze development Citation 
OR (95% CI) Cases Controls 
Belgium Prospective 
birth cohort 
3 weeks 3 weeks 
6 months 
12 months 
ISAAC 
questionnaires 
completed by 
parents 
11.8 
18.4 
23.5(154) 
Culture-based Clostridium¤ 
Bifidobacterium 
Staphylococcus¤ 
0.53 (0.30 - 0.92)  
1.04 (0.99 - 1.09) 
0.95 (0.90 – 1.00)  
NR 
NR 
NR 
NR 
NR 
NR 
Verhulst et 
al., 2008 
Canada Prospective 
birth cohort 
3 months 3 months Doctor-diagnosed 
during API 
assessment 
&  
ISAAC 
questionnaires 
completed by 
parents 
42.6 
(136/319) 
16S rRNA 
sequencing 
and 
quantitative 
PCR (qPCR) 
Faecalibacterium¤ NR NR NR Arrieta et al., 
2015 
1 year 6 months Lachnospira¤ NR NR NR 
 12 months Veillonella¤ NR NR NR 
 3 & 5 years Rothia¤ NR NR NR 
  Bifidobacterium¤ NR NR NR 
Nether-
lands 
Prospective 
birth cohort 
1 month 2 years ISAAC 
questionnaires 
completed by 
parents  
10 (957) 
 
Quantitative 
real time PCR 
Bifidobacteria 
Escherichia coli 
Clostridium difficile 
B. fragilis group 
Lactobacilli 
1.32 (0.85 - 2.06) 
1.92 (0.80 - 4.59) 
1.75 (1.09 - 2.80) 
1.20 (0.66 - 2.18) 
1.22 (0.77 - 1.93) 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
Penders et 
al., 2007 
Nether-
lands 
Prospective 
birth cohort 
1 month 2 years ISAAC 
questionnaires 
completed by 
parents 
 10 (957) Quantitative 
real time PCR 
Toxigenic Clostridium 
difficile 
 
Non-toxigenic Clostridium 
difficile 
3.92 (1.62 - 9.44) 
 
 
1.48 (0.88 - 2.47) 
NR  
 
 
NR 
NR  
 
 
NR 
Penders et 
al., 2008 
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Nether-
lands 
Prospective 
birth cohort 
1 month 7 months 
12 months 
24 months 
4-5 years 
6-7 years 
Parentally 
reported wheezing 
at 7 months, 12 
months, 24 
months, 4-5 years, 
and 6-7 years 
 
16.9 
(420/2479
ɸ) 
8.0 
 (154/1923Ʊ) 
 
Quantitative 
real time PCR 
Clostridium difficile 
Bifidobacterium spp. 
Escherichia coli 
Bacteroides fragilis 
Lactobacillus spp. 
1.38 (1.05 - 1.81)¥ 
1.96 (0.71 - 5.39)¥ 
1.22 (0.81 - 1.84)¥ 
0.89 (0.66 - 1.21)¥ 
0.96 (0.73 - 1.26)¥ 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
NR 
Van 
Nimwegen et 
al., 2011 
Spain Prospective 
birth cohort 
Birth 
 
1 year 
4 years 
Parental reports on 
wheezing and 
medication used 
for wheezing 
during the fourth 
years of age 
31.6 (6/20) 454 GS-FLX 
Titanium pyro-
sequencing 
Meconium microbiota type 
Aƍ and type BҨ 
0.62 (0.09 - 4.40) 
 
 
NR NR Gosalbes et 
al. 2013 
United 
Kingdom 
Prospective 
birth cohort 
3 years 3 years At least 3 
parentally 
reported wheezy 
episodes 
50 (33/66) 
 
PCR-DGGE Lactic acid bacteria 
Bifidobacterium spp. 
NR  
NR 
12 
30 
11 
31 
Murray et al., 
2005 
FISH Bifidobacterium adolescentis 
Bifidobacterium bifidum 
Bifidobacterium longum 
Bifidobacterium catenulatum 
Bifidobacterium 
pseudocatenulatum 
NR 
NR 
NR 
NR 
NR 
28 
4 
13 
1 
2 
30 
5 
12 
1 
2 
 
Significant results are highlighted in boldface 
API: Asthma Predictive Index; CI: Confidence interval; DGGE: Denaturing gradient gel electrophoresis; FISH: Fluorescent in-situ hybridization; ISAAC: International Study of Asthma and Allergies in children; n: 
Number tested positive; N: Total number tested; NR: Not reported; OR: Odds ratio; PCR: Polymerase chain reaction  
ɣ p = 0.01, but no confidence interval reported  
§ Bacteroides fragilis, Bacteroides finegoldii and Bacteroides thetaiotaomicron  
Ϯ Ruminococcus productus, Ruminococcus hansenii and Clostridium spp. 
‡ Eubacterium contortum, Clostridium oroticum, and Ruminococcus torques 
ƍ  Family Enterobacteriaceae as the most abundant bacterial taxon 
Ҩ  Families Leuconostocaceae, Enterococcaceae and Streptococcaceae as the most abundant bacterial taxa 
¥ Generalized estimating equations of wheeze measured at 7, 12 and 24 months and 4-5 and 6-7 years 
ɸ Prevalence of wheezing at 12 months 
Ʊ Prevalence of wheezing at 6-7 years 
Ω No significant characteristics of intestinal microflora in the wheezing case 
¤ Bacteria associated with reduced risk of wheezing in infants 
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Figure 2.3. Age at which wheezing was reported in all the nine studies under investigation.  
There is a total of nine studies included which reported wheezing at one or more different time periods. The time 
periods were 0-1 years, 2-3 years, 4-5 years and 6-7 years. 
 
 
 
2.5. Discussion  
 
 
The main finding of this systematic review was the association observed between the four FLVR 
bacterial genera and the development of atopic wheezing in infants at high risk of developing 
asthma (Arrieta et al., 2015). All four bacterial genera were found to be significantly reduced at 
three months of age in the faeces of atopic wheezing children in the Canadian study, suggesting 
that they play a protective role in preventing wheezing illness (Arrieta et al., 2015). The murine 
lung inflammation research by the Canadian group showed that supplementation with the FLVR 
bacteria significantly reduced the inflammation in the mice (Arrieta et al., 2015). This 
supplementation can be used as a potential preventative method against the development of 
asthma later on in life, in children at risk. The identification of these key bacterial genera opens 
up the idea of a more focused research approach on select bacterial types in the development of 
wheezing in children. If the same results are observed all over the world, these bacteria could be 
0
10
20
30
40
50
60
70
0-1y 2-3y 4-5y 6-7y
Pe
rc
en
ta
ge
 o
f s
tu
di
es
 (%
)
Age
 
  
24 
used for therapeutic interventions to restore balance to the gut bacteria in infants likely to develop 
wheezing. 
 
Three studies from the same cohort observed an association between C. difficile and the increased 
risk of wheezing illness in young children (Penders, Thijs, P. a van den Brandt, et al., 2007; 
Penders et al., 2008; Van Nimwegen et al., 2011). This finding is supported by Woodcock and 
colleagues who showed that C. difficile IgG antibody levels were significantly higher in allergic 
infants with recurrent wheeze compared to non-wheezy infants (Woodcock et al., 2002). It is 
also hypothesized that the role of faecal C. difficile in the occurrence of wheezing is to disrupt 
the infant’s immune system development (Azad and Kozyrskyj, 2012). The use of antibiotics in 
infants prompts the emergence of C. difficile and the suppression of commensal bacteria which 
would be involved in the development of the immune system (Wilson, 1993; Chang et al., 2008; 
Murgas Torrazza and Neu, 2011; Azad and Kozyrskyj, 2012; Theriot et al., 2014). This 
unbalanced/dysbiotic gut then increases the probability of developing wheezing in the infant, 
since the protective bacteria would be absent. Though the specific mechanism that links the gut 
microbiota and infant wheezing is unclear, there are some recent studies that have identified a 
significant amount of crosstalk between gut microbiota and host immune cells (Vital et al., 2015, 
Fosythe 2011). Dendritic cells present in the gut, and in other mucosal site like the lungs, 
transport bacterial antigens to lymph nodes where they can influence local immune responses 
(Hill & Artis 2011, Salzman 2011, Samuelson et al., 2015). This interaction therefore 
significantly increases the risk of development of respiratory diseases (Hill & Artis 2011). The 
paper by Claassen-Weitz and colleagues summarizes the proposed gut microbiota and infant 
wheeze mechanisms well (Claassen-Weitz et al., 2016). 
 
 
  
25 
Previous studies have reported an association between prenatal and early antibiotic exposure and 
the development of wheezing (Lapin et al., 2015; Popovic et al., 2016; Han et al., 2017). 
Alternatively, C. difficile may itself be a specific risk factor for the development of wheezing, 
independent of antibiotic use. Van Nimwegen and colleagues used mediation analysis to confirm 
the intermediary role by C. difficile in the association of mode and place of delivery and 
development of atopy (Van Nimwegen et al., 2011). The reason was that gut colonization by C. 
difficile might act as an intervening factor between birth mode and development of asthma and 
atopic diseases (Van Nimwegen et al., 2011). C. difficile mediation was found for vaginal 
hospital delivery versus caesarean section delivery, as well as vaginal home delivery in 
association with asthma (Van Nimwegen et al., 2011). Infants delivered vaginally at home would 
potentially be colonized by C. difficile since they were likely to be exposed to minimal or no 
medication, when compared to those delivered in hospital (Van Nimwegen et al., 2011). The 
above findings strengthen the association caused by mode of delivery on the development of 
atopic outcomes. Furthermore, another included study demonstrated the importance of 
genotyping in association studies by investigating the difference between toxigenic and non-
toxigenic C. difficile in wheeze development (Penders et al., 2008). Penders and colleagues 
demonstrated that recurrent wheezing was only associated with toxin-positive C. difficile and not 
its toxin-negative counterpart which is also found in same environment (Penders et al., 2008). 
Therefore it is necessary for association studies to go a step further than describing bacteria to 
genus and species level, in order to determine the specific bacterial type responsible for 
development of wheezing.  
 
Three studies included in this review investigated the association between wheezing illness and 
colonization by Bifidobacteria in infants (Verhulst et al., 2008; Amberbir et al., 2011; Arrieta et 
al., 2015). Two of these studies concluded that colonization by Bifidobacteria was associated 
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with increased probability of wheezing (Verhulst et al., 2008; Amberbir et al., 2011). However, 
the study by Arrieta and colleagues did not observe any differences in the proportions of 
Bifidobacteria between controls and atopic wheezing children (Arrieta et al., 2015). A possible 
explanation for the differences could be attributed to breastfeeding, since Bifidobacteria 
colonization has been shown to be associated with breastfeeding (Hesla et al., 2014; Parra-Llorca 
et al., 2018). Breastfeeding has also been shown to be protective against wheezing by multiple 
mechanisms some of which include modulating microflora and promoting gastrointestinal 
mucosa maturation (Oddy, 2004). Therefore, more research needs to be carried out to fully 
explain the effect of breastfeeding with regards to wheezing in different communities. The use 
of probiotics, prebiotics, or symbiotics for the modulation of gastrointestinal microbiome was 
not reported in studies included in this review. Previous findings from three independent meta-
analysis studies suggest that probiotics do not significantly reduce wheezing in infants (Azad et 
al., 2013; Elazab et al., 2013; Zuccotti et al., 2015). Similarly, a meta-analysis based on two 
studies suggested the evidence for the protective role of prebiotics in the development of 
wheezing illness was low (Osborn and Sinn, 2013). More strain specific research needs to be 
carried out in this field to determine the influence of prebiotics and probiotics in the development 
of wheezing, since some probiotic benefits have been observed to be strain related (Ling et al., 
2015).  
 
Most of the studies included in this review assessed the GIT microbial community by use of 
culture-dependent or culture-independent methods which are limited in their strength of 
providing a comprehensive picture of the contribution of specific microbial community groups 
in the occurrence of wheezing illness. Only two studies (conducted in Spain and Canada) used 
massively parallel sequencing to assess this issue (Gosalbes et al., 2013; Arrieta et al., 2015). 
Using NGS, the Canadian birth cohort study was able to successfully determine differentially 
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abundant genera between infants that wheezed and those that did not. They singled out the FLVR 
bacterial genera, that were significantly reduced in the wheezing children at the age of three 
months (Arrieta et al., 2015). However, at one year of age only two of the bacterial genera 
(Veillonella and Lachnospira) had significant differences between the controls and the atopic 
wheezing children (Arrieta et al., 2015). Though 16S sequencing is very informative, it can only 
provide information with confidence up to the genus level, other methods would be needed to 
obtain species-level information. Since the early 2000’s the cost of sequencing has been 
decreasing dramatically, thus future studies can employ strain-specific bacterial typing by using 
whole-genome shotgun-based method which offers higher and more reliable resolution of the 
composition of the microbiota at species-level (Morgan and Huttenhower, 2014; Van Dijk et al., 
2014). Furthermore, more studies have been investigating the metabolic role played by bacteria 
in pathogenesis of diseases, since the bacteria also play a role in the metabolic processes of the 
human body (Morgan and Huttenhower, 2014; Arrieta et al., 2015; Cardet, Johns and Savage, 
2015). The Canadian study found that faecal acetate was significantly reduced in atopic wheezing 
infants in comparison to the controls (Arrieta et al., 2015). This is significant as acetate, a short-
chain fatty acid (SCFA), is a microbe-derived metabolite. Acetate, propionate and butyrate are a 
few examples of SCFA that have beneficial anti-inflammatory properties in human subjects in 
relation to various health conditions such as Crohn’s diseases and atopic wheezing (Morgan and 
Huttenhower, 2014; Arrieta et al., 2015). Cardet and colleagues observed that bacteria derived 
metabolites were involved in the health state in relation to asthma and development of non-
asthmatic wheeze (Cardet, Johns and Savage, 2015). Cardet and colleagues also observed that 
subjects presenting with higher lignan metabolite enterolactone had reduced diagnosis of current 
asthma and non-asthmatic wheeze (Cardet, Johns and Savage, 2015). In addition, other studies 
have also supported the anti-inflammatory role played by the other metabolites including 
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prostaglandin F2 alpha and allantoin in respiratory diseases (Skoner et al., 1989; Chiu et al., 
2018). 
 
One of the studies only observed differences in a few taxa when a comparison of the relative 
abundance was carried out at three months, versus one year (Arrieta et al., 2015). They 
hypothesize that these differences were not detected at one year because the ‘critical window’ of 
the first one hundred days of life, in which gut microbial dysbiosis associated with wheezing 
illness can be detected had passed (Van Der Velden et al., 2001; Arrieta et al., 2015) . After the 
hypothesized ‘critical window’ has passed, no major differences can be observed between the 
bacterial profiles of the wheezers and non-wheezers (Van Der Velden et al., 2001; Arrieta et al., 
2015). More studies are required to confirm the ‘critical window’ when it comes to wheeze 
development in infants from different regions. Furthermore, additional independent longitudinal 
studies with multiple sampling points that fall within the critical window are required to better 
define the progression, with regards to the relative taxa abundance of the bacteria associated with 
wheezing, including the FLVR bacteria. These studies would provide more insightful missing 
information on this topic.  
 
Limitations to this systematic review are that most of the eligible studies did not conduct rigorous 
statistical analysis to account for confounding factors that may be associated independently with 
wheeze, as well as influencing faecal bacteria profiles. The majority of the studies were 
conducted in developed countries except for the one study in Ethiopia. Therefore, it would be of 
great interest to perform similar studies in many low- and middle-income countries. This is of 
particular interest, since differences in microbial communities are reported between developed 
and developing countries (De Filippo et al., 2010; Grześkowiak et al., 2012; Yatsunenko et al., 
2012; Lin et al., 2013; Ou et al., 2013; Suzuki and Worobey, 2014). The contribution of the 
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bacterial community in the occurrence of wheezing in Africa is currently unknown; therefore, 
more studies are warranted in different populations across the continent. Furthermore, the 
definitions of outcomes assessed in this review were heterogeneous and observed at different 
ages (Murray et al., 2005; Penders et al., 2007, 2008; Verhulst et al., 2008; Amberbir et al., 2011; 
Van Nimwegen et al., 2011; Gosalbes et al., 2013). For example, Arrieta and colleagues defined 
their main outcome as atopic wheezing, which was the presence of a positive allergen skin prick 
test and one or more wheezing episodes in the first year of life (Arrieta et al., 2015). On the other 
hand, Van Nimwegen and colleagues defined their outcome as wheezing according to the 
International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire (Van 
Nimwegen et al., 2011). The different outcome definitions do not allow for a full comparative 
analysis since the outcomes exhibit varying degrees of wheezing illness intensity. According to 
previous literature, infant wheezing is more prevalent in the first three years of life (Martinez et 
al., 1995). Most of the studies included in this review fall in this range (Nambu, Shintaku and 
Ohta, 2004; Penders, Thijs, P. a van den Brandt, et al., 2007; Penders et al., 2008; Verhulst et 
al., 2008; Van Nimwegen et al., 2011; Gosalbes et al., 2013; Arrieta et al., 2015). The studies 
with infants three years and older have a potential to produce less information, as the prime 
period in which wheezing occurs would have passed (Murray, Tannock, Simon, Harmsen, 
Welling and Custovic, 2005a; Amberbir et al., 2011). In addition, studies that have postulated 
about the ‘critical window’, mention it being in the first 100 days of life, this is a time period in 
which microbial dysbiosis can be linked to wheezing or allergic disease (Russell et al., 2012; 
Arrieta et al., 2015). Therefore, bacterial investigations outside this 100 day age range would 
most likely not be able to show the same information with regards to microbial dysbiosis that 
can be linked to wheezing illness.  
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2.6. Conclusion  
 
Few studies have reported on the significant associations between faecal bacteria and wheezing. 
Most of these studies had small sample sizes and used target-based approaches for studying the 
bacterial community. Future studies would require large, longitudinal birth cohort studies that 
use high-resolution experimental methods for microbiota analysis. This exhaustive analysis 
would enable researchers to extensively understand the role of faecal microbial profiles in the 
development of wheezing illness in both developed and developing countries. Finally, further 
research from other cohorts assessing the association between the FLVR bacteria, C. difficile 
colonization and wheezing illness in young children is required. The reason would be all the 
publications reported here were generated from the same cohort and were thus not independent. 
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Chapter 3 - Association between Faecal 
Bacteria and the Development of Recurrent 
Wheezing among Infants within the 
Drakenstein Child Health Study 
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3.1.  Abstract  
 
Background: Multiple studies have investigated the association between infant stool 
microbiota and wheezing illness. However, these studies have not been conclusive due to 
limitations such as targeted experimental techniques and small sample sizes. Therefore, to gain 
greater insight into the association between wheezing illness and the stool microbiota, we 
conducted a prospective, longitudinal study that investigated recurrent wheezing in infants 
using next-generation sequencing techniques.  
Methods: The infants were from the Drakenstein Child Health Study found in the Western 
Cape, South Africa. Cases in this study were defined as infants who wheezed at least once in 
the first year of life. Controls were infants who had not wheezed at all during this time frame. 
We collected faecal samples from the infants at birth, six weeks, six months and 12 months. 
We extracted nucleic acid from all the faecal samples using the manual ZR Fecal DNA 
MiniPrep™ Kit. This was followed by the sequencing of the V4 region of the 16S rRNA gene 
using the Illumina MiSeq technique. Bioinformatic quality control checks were performed on 
the sequencing data. Thereafter, the contaminating genera were removed and statistical 
analysis was carried out. Relative abundance curves and bar plots were generated for the infant 
samples. Additionally, we plotted log ratio bi-plots to ascertain differences between the faecal 
bacterial profiles of infants in relation to the frequency of wheezing during the first year of life. 
Results: At birth, 159 infants provided faecal samples. The remaining infant samples were 
collected as follows: 114 at six weeks, 141 at six months and 98 samples at 12 months of age. 
For the infants, 140 cases and age-matched controls were included in this study. The infant 
bacterial profile varied during the first year of life, becoming more stable over time. By six 
weeks of age, 16% of the infants had wheezed once and 8% had wheezed twice or more times. 
There was no clustering observed between the frequency of wheezing and the associated 
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bacterial profiles at the different ages. The results of this study show that the composition of 
Lactobacillales in the infant stool were associated with the development of recurrent wheezing.  
Conclusion: The passed and aspirate samples were found to be very similar. Significant 
differences between the wheezing outcomes were observed in the infant stool composition of 
Lactobacillales, though they were due to outliers. The results of this study do not show an 
association between wheezing and the FLVR (Faecalibacterium, Lachnospira, Veillonella and 
Rothia) bacteria.  
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3.2. Introduction  
 
 
Wheezing illness is a high-pitched whistling sound made while breathing (Kusel et al., 2007). 
It affects at least 50% of children under the age of 5 years, with about 20% of the infants 
wheezing twice or more times in the first 12 months of life (Martinez et al., 1995; Nriagu et 
al., 1999; Sunyer et al., 2001; Smuts, Workman and Zar, 2011). Recurrent wheezing has 
varying inconsistent definitions (Remes et al., 2001; Ly et al., 2006; Blanken et al., 2013). In 
this study, we will refer to it as two or more wheezing episodes within 12 months, as it is not 
prevalent in the first year of life (Ly et al., 2006). It is worth noting that approximately 30% of 
preschool age children with recurrent wheezing will have asthma at six years of age (Taussig 
et al., 2003). Panettieri and colleagues observed that children who wheezed recurrently in the 
first year of life presented with decreased lung function and increased respiratory infections 
(Panettieri et al., 2008). A handful of researchers across the world have investigated the 
association between infant gut microbiota and wheezing illness in children (Murray et al., 
2005; Vael et al., 2008, 2011; Gosalbes et al., 2013; Arrieta et al., 2015; Stiemsma et al., 2016). 
However, in Africa, only one study according to our knowledge has investigated the 
association between infant gut bacterial profiles and wheezing illness (Amberbir et al., 2011).  
 
Two recent publications from the CHILD Study have provided substantial evidence of the 
involvement of four main faecal bacterial genera in the development of wheezing in infants 
(Arrieta et al., 2015; Stiemsma et al., 2016). Arrieta and colleagues discovered that the FLVR 
bacteria were significantly reduced at three months of age and not at one year, in the atopic 
wheeze group (Arrieta et al., 2015). This discovery led the researchers to come to the 
conclusion that the FLVR bacteria offer a protective effect in infants against the development 
of wheezing (Arrieta et al., 2015). In this same study they were able to demonstrate the causal 
relationship between wheezing and the FLVR (Faecalibacterium, Lachnospira, Veillonella 
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and Rothia) bacteria, with the use of a murine model of airway inflammation using humanized 
bacteria (Arrieta et al., 2015). The follow-up study by Stiemsma and colleagues showed that 
atopic wheezing infants had reduced amounts of Lachnospira and increased amounts of C. 
neonatale (Stiemsma et al., 2016). The results from these two studies probe the idea that only 
a fraction of the stool bacteria are responsible for the development of wheezing, and not the 
entire stool bacterial composition. 
 
Most of the studies investigating wheezing illness and the infant bacteria have been in high 
income countries, used culture and targeted experimental techniques to identify the infant stool 
microbial community and approximately 33 % of them consisted of small sample sizes, ranging 
from 18 to 76 participants (Kalliomäki et al., 2001; Bisgaard et al., 2011; Akay et al., 2014). 
Therefore, we have carried out this study within a prospective birth cohort in a low socio-
economic community in South Africa. The objectives of this study were to describe the major 
components of the faecal bacterial profile during the first year of life of infants with and without 
wheezing, determine the risk factors influencing that composition and to investigate the 
association between the stool bacteria and the development of recurrent wheezing in infants.  
  
 
3.3. Methods 
 
3.3.1. Ethics Statement 
 
Both the Drakenstein Child Health Study (DCHS) (HREC: 401/2009) and this study (HREC: 
748/2015) received approval from the University of Cape Town (South Africa) Human 
Research Ethics Committee (HREC). Approval letter of this study is included in Appendix D.  
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3.3.2. Study Setting and Design 
 
This longitudinal study was nested within a birth cohort study, referred to as the DCHS (Zar et 
al 2015). The DCHS is located in the Drakenstein sub-district, 60 kilometres outside of Cape 
Town, South Africa (Figure 3.1).  The DCHS study has enrolled about 1000 mother/infant pairs 
and followed the children from birth up to five years of age. The main aims of the DCHS 
include the investigation of aetiology, progression and risk factors for childhood pneumonia. 
This population is stable which makes it ideal for the longitudinal study, and they have access 
to child health care and antenatal services (Zar et al., 2015). Pregnant mothers were enrolled 
at either Paarl Hospital or other neighbouring primary health care facilities; Mbekweni and TC 
Newman clinics. Participants included in this study required informed consent from the 
mothers and confirmation that they were residents of the area and would not be moving during 
the study period. Infants were enrolled at birth and subsequent samples were collected from six 
weeks to 12 months of age.   
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Figure 3.1. Geographical location (in red) of the Drakenstein Child Health Study, Western Cape, South 
Africa. The red in the insert depicts the Western Cape Province, while the red in the main figure outlines the 
Paarl sub-district. 
Source for country map:http://en.wikipedia.org/wiki/Administrative_divisions_of_South_Africa#/media/File:M
ap_of_South_Africa_with_English_labels.svg Source for province map: http://commons.wikimedia.org/wiki/Fil
e:Map_of_the_Western_Cape_with_municipalities_labelled_(2006).svg  
 
 
3.3.3. Selection of the Study Population   
 
Pregnant women were enrolled from Mbekweni and TC Newman clinics between 20-28 weeks 
of gestation. Participants were selected for this study based on the availability of infant samples 
collected at birth, 6 weeks, 6 months and 12 months. We defined a case as an infant who 
wheezed at least once in the first year of life. The first wheezing outcome was an infant who 
wheezed once in the first year of life. The recurrent wheezer was the second outcome and 
defined as an infant who wheezed two or more times in the first year. Samples of infants 
reported to have wheezed in the first 12 months were identified first, and then age-matched 
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controls were included thereafter. Therefore the controls were samples collected from infants 
who did not wheeze at any point during the first year of life. Age matching is a process whereby 
control infants whose samples were collected at ages as close as possible to the cases were 
identified and included in the dataset. The main criteria used to select infant samples from the 
DCHS database was an infant with a stool sample collected within the time points of interest; 
birth, 6 weeks (4 – 8 weeks), 6 months (5 – 7 months), 12 months (11 – 13 months). There 
were two stool sampling types collected from infants in this study, namely: aspirated stool and 
normal passed stool (gastrointestinal tract stool).  
 
3.3.4. Collection of Faecal Samples and Metadata Variables   
 
The first stool samples were collected at the birth of the infant at the hospital. Subsequent stool 
samples were either collected at home or at the clinic. If they were collected at home, they were 
stored at -20ºC until being transported to the clinic where they would then be sent to the 
Division of Medical Microbiology to be stored at -80°C. Samples collected at the clinic were 
transported to the Division of Medical Microbiology, University of Cape Town, on the same 
day and stored at -80°C. Stool samples were collected in sterile, labelled screw-cap containers 
with a scoop attached to the lid.  At the scheduled clinic visits, stool samples were collected 
from the babies, as well as aspirated stool samples were collected from the infants unable to 
pass stool. A thin plastic tube lubricated with K-Y Jelly was attached to a syringe, inserted into 
the anus and used to rinse out the rectum using Molecular grade water (Sigma-Aldrich). The 
aspirate was dispensed into a sterile 2 ml Eppendorf tube and stored at -20°C until 
transportation.  
 
Information regarding medication use (antibiotics) and hospitalization was obtained from the 
mothers. The presence of common risk factors for gut bacterial colonization and wheezing 
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illness were assessed in questionnaires that were performed by healthcare professionals at the 
clinic at all the recorded sample collection points (birth, 6 weeks, 6 months and 12 months). 
Once captured, the data was stored on a central database under the management of the data 
team which verified the entries with the hard copy questionnaires. The questionnaires included 
the following variables: age, gender, mode of delivery, gestational age, current breastfeeding, 
introduction of solids, daycare attendance (assessed at each time point), maternal education, 
maternal employment status and average household income, maternal HIV status, indoor air 
pollution, number of people living in the house and sharing the bedroom with the baby, parental 
smoking as well as pet exposure.  
 
3.3.5. Bacterial DNA Extraction from Faecal Samples 
 
DNA was extracted from approximately 50mg of passed stool or 100μl of aspirated stool using 
the ZR Fecal DNA MiniPrep™ (Catalog No. D6010, Zymo Research, CA, USA), with minor 
changes. We transferred a maximum of 600μl of the supernatant to the Zymo-Spin™ IV Spin 
Filter so as to maximise the amount of DNA being processed. 
 
 
3.3.6. DNA Concentration and DNA Purity  
 
The bacterial DNA concentration and purity were determined to assess the quality of the 
samples before library preparation for NGS. The bacterial DNA concentration was measured 
by using a quantitative PCR, according to the protocol by Bogaert (Bogaert et al., 2011). The 
purity of the DNA was assessed using the NanoDrop spectrophotometer (Thermo Scientific 
NanoDrop 2000 Spectrophotometer, Thermo Scientific, Wilmington, DE 19810 USA). DNA 
samples failing to amplify were excluded from library preparation. The 260/280 and 260/230 
ratios from the nanodrop were used to assess the purity of the nucleic acid. The best 260/280 
ratios range from 1.8 to 2.0, and anything outside this range indicates the presence of 
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contaminants such as phenols and proteins that absorb at 280nm. The optimum 260/230 ratios 
range from 2.0 to 2.2, and anything outside this range indicates the presence of contaminants 
that absorb at 230nm. 
 
3.3.7. 16S ribosomal RNA gene Library Preparation 
 
Figure 3.2 summarizes the sequence of steps for library preparation of the 16S rRNA gene 
for the samples under investigation.  
 
 
Figure 3.2. Flow diagram representing the various steps involved in the 16S rRNA Library Preparation. 
 
 
3.3.7.1. PCR Amplification of 16S ribosomal Bacterial DNA 
 
Two PCR reactions were carried out to amplify and add barcodes to the V4 hypervariable 
region of the 16S rRNA gene, with minor modifications (Caporaso et al., 2011).  
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3.3.7.2. 16S rRNA Short PCR  
 
The first PCR was performed in 25.25μl and contained 1X MyTaqTM HS Mix (Bioline, MA, 
USA), 0.8μM of each modified primer F515 short: (5’ GTGCCAGCHGCYGCGGT 3’) and 
R806 short: (5’ GGACTACNNGGGTWTCTAAT 3’), 2.97% dimethyl sulfoxide (Sigma-
Aldrich®, MO, USA) and 4μl of template DNA per sample. Cycling conditions of the first PCR 
included an initial denaturation step at 95ºC for 3 min, 10 cycles of denaturation at 95ºC for 30 
sec, annealing at 50ºC for 30 sec and extension at 72ºC for 1 sec; followed by a final extension 
step at 72ºC for 5 min. Each PCR run included a positive (25 ng Cyanobacteria genomic DNA) 
control, non-template controls and technical repeats with 4μl of template DNA. PCR reactions 
were performed in an Applied Biosystems® 2720 Thermal Cycler (CA, USA).  
3.3.7.3. 16S rRNA Long PCR 
 
The second PCR reaction included the primers F515-composite (5′- 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGA
TCTNNNNNNNNNNGTGCCAGCHGCYGCGGT-3′) and R806-composite 
(5′CAAGCAGAAGACGGCATACGAGATACGAGACTGATTGTGACTGGAGTTCAGA
CGTGTGCTCTTCCGATCTNNNNNNNNNNNNGGACTACNNGGGTWTCTAAT-3′) 
(Caporaso et al., 2011). This PCR reaction of 25.25μl contained 1X MyTaqTM HS Mix (Bioline, 
MA, USA), 0.8μM of each primer, 2.97% dimethyl sulfoxide (Sigma-Aldrich®, MO, USA) 
and 4μl of amplicon from the first PCR reaction. In the second PCR, the amplicon from the 
first PCR was used to attach the adapters, and this reaction also included barcodes, priming 
region and 12-15 staggered nucleotides (NNNNNNNNNNNNN). The cycling conditions were 
identical to the first PCR, except that the PCR included 30 cycles.  
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3.3.7.4. PCR Amplicon purification and quantification 
 
PCR amplicons from the second round were purified using Agencourt AMPure XP (Beckman 
Coulter, CA, USA), following the manufacturer’s guidelines with one modification. The 
modification applied in this study entailed dispensing 16.25μl (0.65 x 25μl reaction volume per 
well) beads into each well and pipette mixing. We lastly transferred 35μl of the eluent to a new 
plate and stored at 4°C. 
 
The quantification of the purified PCR product was done using the QuantiFluor® dsDNA 
System in 96 well plates according to the manufacturer’s instructions. The GloMax®-Multi 
Microplate Multimode Reader (WI, USA) was used to quantify each of the purified amplicons. 
3.3.7.5. PCR Amplicon size verification 
 
Aliquots of purified PCR amplicons (5µl) were loaded onto 2% agarose gels containing 
0.1µg/ml of Ethidium Bromide. TrackIt™ 1 Kb Plus DNA Ladder (Thermo Fischer, USA) 
(5µl) was loaded on all agarose gels. Agarose gels were electrophoresed for 90 min at 110 
Volts. Agarose gels were viewed using the Chemi Genius 2 Bio Imaging System (CA, UK).  
3.3.7.6. Pooling of PCR Amplicons 
 
Based on the amplicon concentrations measured above, the required volume for each purified 
amplicon was calculated in order to contribute towards the 80ng of pooled DNA. The 96 well 
plates were spun before transferring the estimated amplicon amounts from each well to a 1.5ml 
Eppendorf tube.   
3.3.7.7. Quantification of Pooled PCR Amplicons 
 
The amplicon pooled DNA was quantified using the Qubit® dsDNA BR Assay Kit 
(Invitrogen™, Eugene, OR, USA) according to the manufacturer’s recommendations. This kit 
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was used because it measures double-stranded DNA in the concentration range from 100pg/µl 
to 1000ng/µl. 
 
3.3.7.8. Purification of Pooled PCR Amplicons 
 
Pooled DNA was purified using the Agencourt AMPure XP (Beckman Coulter, CA, USA) 
following the manufacturer’s guidelines with the following modification; beads were 
dispensed in a 1:1 ratio. We transferred 60μl of the eluent to a new tube and stored at 4°C. The 
purified pooled DNA was quantified as above. 
 
3.3.7.9. Size verification of Pooled PCR Amplicons 
 
A 1.5% agarose gel containing Ethidium Bromide (0.1µg/ml) was prepared. Three wells of the 
comb were taped together, to create a large well that could hold more volume of sample. This 
large well allowed 6µg of amplicon pooled DNA with loading dye to be loaded into it. 
TrackIt™ 1 Kb Plus DNA Ladder (Thermo Fischer, USA) was included on the agarose gel. In 
addition, 20µl of Ethidium Bromide was added to the Tris-Acetate EDTA buffer tank at the 
anode end (at the red electrode). Gel electrophoresis conditions were set as follows: 35 volts 
for 30 min, then 40 volts for 45 min and finally 70 volts for 3 hrs 30 min. Agarose gels were 
viewed on a long wavelength (312nm) FOTODYNE Transilluminator (WI, USA) to excise 
DNA ranging between 400bp and 500bp from the gel, using a sterile blade. The gel slice was 
trimmed to remove excess gel before placing the DNA-containing gel slice in a sterile 1.5ml 
Eppendorf tube and viewing it using the Chemi Genius 2 Bio Imaging System (CA, UK). 
 
DNA was purified from the agarose gel slices using the QIAquick Gel Extraction Kit (USA), 
according to the manufacturer’s guidelines.  
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3.3.7.10. Quantification of Pooled Amplicons 
 
Gel extracted DNA was quantified using the Qubit® dsDNA BR Assay Kit (Invitrogen™, 
Eugene, OR, USA) according to the manufacturer’s recommendations.  
 
 
3.3.8.  Sequencing of 16S ribosomal RNA V4 region  
 
Faecal samples collected from the infants, as well as a set of controls were sequenced in two 
sequencing runs by the Centre for Proteomic and Genomic Research (CPGR), Cape Town, 
South Africa. Sequencing run 1 contained 245 samples and 24 sequencing controls. Sequencing 
run 2 contained 267 samples and 18 sequencing controls. The sequencing controls for each run 
consisted of two positive controls; genomic DNA from a mock microbial community known 
as a BEI control (HM-783D, BEI Resources, VA, USA) and genomic DNA from 
Cyanobacteria (Arthrospira). The other controls included were non-template controls which 
consisted of no-template DNA extraction controls and Cyanobacteria spiked no-template DNA 
extraction controls, as well as technical repeats which consisted of nucleic acid randomly 
selected from the samples. 
 
CPGR conducted a quality control check which entailed the quantitation of adapter-ligated 
double-stranded DNA (dsDNA) on the 7900HT Fast Real-Time PCR System using the KAPA 
Library Quantification Kits (Illumina®), and analysis of fragment size distribution on the 
Agilent 2100 Bioanalyzer using the Agilent High-Sensitivity (HS) DNA Kit. Thereafter, the 
library pool was diluted to 4 nM using Buffer EB (Qiagen, DE). A 5 μl aliquot of the 4 nM 
library was denatured by adding 5 μl of 0.2 N NaOH. The mixture was incubated at room 
temperature for 5 min, and 990 μl of HT Buffer (Illumina®) was added to bring the library 
concentration to 20 pM. The library was further diluted to 4 pM with HT Buffer. The PhiX 
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library was diluted from 10 nM to 4 nM with Buffer EB and then denatured as above and 
diluted to 4 pM. The PhiX library was spiked into the library at 15% (v/v) and further denatured 
at 96 °C for 2 min and incubated on ice for 5 min before loading onto the MiSeq® instrument 
for sequencing using the MiSeq® Reagent v3 kit (600 cycle). The MiSeq® system was 
programmed for a 2x 251-cycle, paired-end sequencing run to generate FASTQ files.  
 
3.3.9. Bioinformatic and Statistical Analysis 
 
3.3.9.1. Bioinformatic Analysis 
 
The sequencing quality of FASTQ files was analyzed using the Fastqc package (Wang et al., 
2007; Andrews, 2010; Edgar, 2010, 2013). UPARSE and USEARCH were used to assess, sort, 
carry out the dereplication, clustering and chimera removal from the sequences as described 
by Pylro and colleagues (Wang et al., 2007; Edgar, 2010, 2013; Pylro et al., 2014). A few 
modifications to the above protocol included the removal of contamination as detailed below, 
and the use of SILVA database for taxonomy assignment. The faecal sample sequences with a 
matching identity of 100% to no-template control sequences were removed from the faecal 
samples if they had the same or lower number of reads compared to the average reads of the 
contaminant Operational Taxonomic Units (OTUs) in the controls. Otherwise, the average 
number of reads of the contaminants were subtracted from the matching biological sequences. 
Further processing of the data was carried out using the Quantitative Insights Into Microbial 
Ecology (QIIME 1.7.0) suite of software tools (Caporaso et al., 2010). The taxonomy was 
therefore assigned as mentioned by Claassen-Weitz and colleagues (Claassen-Weitz et al., 
2018). Rarefaction curves were calculated for all the samples included in this study. 
3.3.9.2. Statistical Analysis 
 
The software applications used in this study for statistical analysis and graphical data 
representations were R 3.4.1 and RStudio 1.1.414. The output from the Illumina MiSeq 
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sequencing software QIIME was used for the downstream statistical analysis. The R packages 
used for the analysis included biomformat, car, cluster, MASS, psych, smacof and vegan 
(Venables and Ripley, 2002; de Leeuw and Mair, 2009; Fox and Weisberg, 2011; Hastie, 2013; 
Oksanen, Blanchet and Kindt, R, 2013; Maechler et al., 2015; McMurdie and Paulson, 2016; 
Liaw and Wiener, 2018; Revelle, 2018). Box plots were drawn to graphically show the 
statistically significant different medians at 5% significance (p<0.05).  
3.3.9.3. Analysis of the Sociodemographic Data 
 
R package epicalc was used to describe the characteristics of the participants, with the use of 
summ and tab1 functions. The clinical data in conjunction with the relative abundance data 
was analysed in R by use of the vegan package and generalised linear models. Anova tests 
were also computed as part of the analysis of variance. A p-value less than or equal to 0.05 was 
considered statistically significant. 
 
3.3.9.4. Calculating beta diversity of aspirate stool samples, passed stool samples and 
spiked aspirate sequencing controls 
 
Beta diversity is a measure of inter-individual diversity which is calculated between different 
samples (Whittaker, 1960). For this reason, the similarity between the aspirate stool and the 
passed stool samples were measured using beta diversity. The first measures used was : 
(Whittaker, 1960), which ignores the relative magnitude of the species found in one sample but 
not the other. The second measure was : (Lennon, J.J., Koleff, P., Greenwood, J.J.D., 
Gaston, 2001) based on (Simpson, 1943), which focuses on compositional difference, more 
than difference in species richness. Beta diversities were computed pairwise, with  
indicating perfect similarity and  indicating complete difference. Here we computed the 
mean beta diversity between the aspirate stool samples, passed stool samples and the spiked 
(using Cyanobacteria) aspirate sequencing controls as shown in Table 3.1. 
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Table 3.1. Table showing how the mean beta diversities were computed between the samples.  
 Sample  Sample   Sample  
Sample      
Sample      
     
Sample      
 
The number of ‘pairwise’ comparisons is , with the values in the upper triangle 
 equal to those in the lower triangle since 
. The values on the diagonal are all zero since it is a measure of the beta 
diversity between a sample and itself. These zero values are included in the computation of the 
mean of all  values. The total of all beta diversity values in the matrix is: 
 
The mean beta diversity of the off-diagonal values is obtained by adjusting the total for division 
by the total number of off-diagonal elements  to obtain: 
 
 
3.3.9.5. Multidimensional scaling of clusters 
 
Multidimensional scaling was executed in order to determine the similarity between the 
aspirated and the passed stool samples included in this study. The smacof R package was 
used to generate the cluster plots (de Leeuw and Mair, 2009). 
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3.3.9.6. Summary Statistics 
 
Box and whisker plots were drawn to show the distribution of the DNA concentrations and 
purities of all the stool samples. 
3.3.9.7. Evaluation of sequencing depth 
 
Accumulation or rarefaction curves were constructed to determine if adequate numbers of reads 
were obtained from all the stool samples of infants, to identify all bacterial genera (Hughes et 
al., 2016). The sequencing efficiency was assessed by constructing accumulation curves of the 
number of genera against the number of reads obtained (richness), using the function [rarefy] 
from the R package vegan (Hurlbert, 1971; Oksanen, Blanchet and Kindt, R, 2013). 
3.3.9.8. Calculation of the Species Richness (Alpha Diversity) 
 
The Shannon diversity index (H’)  was calculated to determine the alpha diversity of the infants 
included in this study (Shannon, 1948; Morgan and Huttenhower, 2012). Alpha diversity 
measures the evenness and richness of bacteria in the sample of interest. A larger Shannon 
diversity index indicates greater diversity within the sample.  
 
 
 
Where ! = species of interest, "!    = proportion of species of interest (!) relative to the total number of species, 
ln    = natural logarithm, 
Σ    = sum of the resulting product across species, and 
s    = number of species recorded. 
 
3.3.9.9. Generation of log ratio biplots using the sequencing data 
 
Log ratio biplots simultaneously plot compositional data on a multidimensional platform 
(McMurdie and Paulson, 2016). We generated log ratio biplots using the compositional data of 
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the samples in the OTUs that were shown to be statistically different, at 5% significance 
(Greenacre, 2010). 
3.3.9.10. Analysis of wheezing relationship in infants 
 
Log ratio bi-plots were generated based on wheezing frequency in the first year of life at both 
phylum and genus level (McMurdie and Paulson, 2016). Coplots of bacterial taxa and 
wheezing variables which included wheeze onset and number of wheezing episodes in the first 
year of life were also generated as part of the analysis of the wheezing relationship in infants. 
 
3.4. Results 
 
3.4.1. Participant Characteristics 
 
3.4.1.1. Sample Collection and Distribution 
 
During the study design, we pre-determined that a subset of 140 cases and 140 age-matched 
controls would be used in the investigation for this nested study. A total of 512 stool samples 
were collected from 280 infants between August 2012 and October 2015 (Figure 3.3). At birth, 
159 infants provided stool samples, in the form of passed stool samples. The remaining infant 
stool samples were collected as follows: 114 collected at six weeks, 141 collected at six months 
and 98 stool samples collected at twelve months of age (Figure 3.3). From six weeks to 12 
months the number of aspirated stool samples ranged from 9 – 33% (Table 3.2). The heat map 
(Figure 3.4) shows the sample collection for the infants at the time points under investigation. 
The heat map also indicates that the majority of the infants did not have stool samples collected 
at all the times points. For the cases, 46 had one sample, 49 had two samples, 20 had three 
samples and 14 had four samples collected. For the controls, 45 had one sample, 44 had two 
samples, 21 had three samples and 14 had four samples collected. 
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Figure 3.3. Schematic of the longitudinal data collection. Samples were collected at birth from the infants 
(159), and the infants were followed up at 6 weeks (114), 6 months (141) and 12 months (98) for 
subsequent stool sample collection. 
  
 
 
Table 3.2. Sample distribution between the two types, aspirated stool and passed stool. 
Age Aspirate stool (%) Passed stool (%) Total 
birth 0 (0) 159 (100) 159 
6 weeks 10 (9) 104 (91) 114 
6 months 21(15) 120 (85) 141 
12 months 32 (33) 66 (67) 98 
 
 
 
 
52 
Time (weeks) 
0 6 26 
Infant 
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Figure 3.4. Heat map of sample collection of the infants from birth to 12 months. Each row represents an 
infant, and the different columns represent the different time points namely birth, six weeks, 26 weeks and 52 
weeks. 
 
3.4.1.2. Study Population 
 
Table 3.3 summarizes the study participants clinical and demographic characteristics as split 
between cases and controls. The median age of the 159 infants that provided a faecal sample 
at birth was one day (25-75 percentile (Q1-Q3; 0 – 1)). The 114 infants that provided a sample 
at six weeks had a median age of seven weeks (Q1-Q3; 6.5 – 8.5), and the 141 infants with a 
six-month sample had a median age of six months (Q1-Q3; 5.8 – 6.2). Lastly, 98 infants 
provided a faecal sample at 12 months, and the median age was 12 months (Q1-Q3; 11.7 – 
12.5). Over 90% of the infants included in this study were full term with a median birth weight 
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of 3.2 kg (Q1-Q3; 2.7 – 3.5), and median birth length of 50 cm (Q1-Q3; 48 – 52). Most of the 
infants (~80 %) were vaginally delivered. Infant smoke exposure from the mother was 57% in 
the cases and ~63% in the controls. The majority of the mothers in both groups (>95%) received 
secondary or tertiary education. 
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Table 3.3. Summary of participant characteristics. 
Characteristics Cases  Controls  
Number 140 140 
Residential Area: 
Mbekweni, n (%) 55 (39.3%) 53 (37.9%) 
TC Newman, n (%) 85 (60.7%) 87 (62.1%) 
Maternal education: 
Primary level, n (%) 6 (4.3%) 3 (2.1%) 
Secondary level, n (%) 126 (90%) 124 (88.6%) 
Tertiary level, n (%) 8 (5.7%) 13 (9.3%) 
Infant HIV status: 
HIV-infected, n (%) 2 (1.4%) - 
HIV-uninfected, n (%) 138 (98.6%) 140 (100%) 
Maternal smoking status: 
Smoker, n (%) 80 (57.1%) 88 (62.9%) 
Non-Smoker, n (%) 60 (42.9%) 52 (37.0%) 
Mode of delivery: 
Vaginal delivery, n (%) 113 (80.7%) 114 (81.4%) 
Caesarean-section delivery, n (%) 27 (19.3%) 26 (18.6%) 
Gestational age (weeks), median (Q1-Q3) § 39 (38-40) 39 (38-40) 
Birth weight (kg) , median (Q1-Q3) § 3.0 (2.7-3.4) 3.2 (2.9-3.5) 
Birth length (cm) , median (Q1-Q3) § 50 (48-52) 50 (49-52) 
Gender: 
Male, n (%) 76 (54.3%) 76 (54.3%) 
Household members, n (Q1-Q3) § 5 (3-6) 5 (3-7) 
§ - Interquartile range 
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3.4.1.3. Wheezing Data 
 
The number of infants experiencing one wheezing episode during the study period increases 
over time from six weeks to 12 months (Table 3.3). At the six-week follow-up, 16% of the 
infants had wheezed once. A further 9% (13/140) of the infants wheezed two or more times in 
the same time frame. At six months 21% of infants wheezed once and a further 31% wheezed 
two or more times. At 12 months, 29% of the infants wheezed once and 16% wheezed twice 
or more, from the age of six months. In this dataset, 40.8% of the infants wheezed once, and 
59,7% wheezed more than once. The heat map shows the distribution of the wheezing in the 
infants over time (Figure 3.5). It also shows that at age 6 months there was the largest 
proportion of infants with more than one wheezing episode in this dataset.  
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Figure 3.5. Heat map of infant wheezing data. 
Each row represents an infant, and the different columns represent the different time points namely; six weeks, 
six months and 12 months. The different colours represent the number of times the infant has wheezed in total up 
to that time point. A blank in the heatmap either means that the infant did not wheeze at that timepoint or the data 
was not available. Forestgreen – 1 wheeze episode, Aquamarine – 2 wheeze episodes, Violet – 3 wheeze episodes, 
Dodgerblue - 4 wheeze episodes, Yellow - 5 wheeze episodes, Orange - 6 wheeze episodes, Red - 7 wheeze 
episodes.  
 
3.4.2. Quality Control of the DNA and Sequencing Data 
 
3.4.2.1. Determination of the Concentration and Purity of the DNA 
 
The baby’s first stool (meconium) sample median DNA concentration was 2.9 ng/μl (Q1-Q3; 
1.7 – 6.2) (Figure 3.6A). The median DNA concentration of the passed stool samples was 
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318.75 ng/μl ( Q1-Q3; 175.92 – 549.25) (Figure 3.6A). The median DNA concentrations of 
the aspirate stool samples were significantly lower than the passed stool samples (19.44 ng/μl 
(Q1-Q3; 6.09 – 57.98) vs 318.75 ng/μl (Q1-Q3; 175.92 – 549.25); p= 8.27E-11). The median 
purity of the passed stool samples as measured by the Nanodrop 260/280 ratio was 1.63 (Q1-
Q3; 1.16 – 1.70) (Figure 3.6B). The median purity of the passed stool samples as measured by 
the Nanodrop 260/230 ratio was 1.10 (Q1-Q3; 0.43 – 1.30) (Figure 3.6C). The median purity 
of the aspirate stool samples as measured by the Nanodrop 260/280 ratio was 1.35 (Q1-Q3; 
1.22 – 1.48) (Figure 3.6B). The median purity of the aspirate stool samples as measured by the 
Nanodrop 260/230 ratio was 0.57 (Q1-Q3; 0.52 – 0.65) (Figure 3.6C).  
 
 
 
Figure 3.6. Qualitative and quantitative analysis of the DNA. 
(A) Concentration of the DNA as determined by 16S qPCR (B) Purity of the DNA (260/280 ratio) as determined 
by the Nanodrop spectrophotometer (C) Purity of the DNA (260/230 ratio) as determined by the Nanodrop 
spectrophotometer. 
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3.4.2.2. Sequencing of Pooled 16S ribosomal RNA gene Libraries 
 
The concentrations of adapter-ligated library in the pooled library samples were 35.5 nM and 
29.75 nM, for Runs 1 and 2 respectively, as determined by the KAPA Library Quantification 
Kit. The average fragment sizes for Run 1 and Run 2 were 459 bp and 448 bp respectively, as 
determined by the Bioanalyzer (Figure 3.7). The cluster density for Run 1 was 502 k/mm2, and 
a total of 5.7 Gb of data was obtained. Of the reads mapped to the indices used, 74.8 % passed 
the filter set by the on-board sequencing software, and 3.7 Gb (64.9%) had a quality score of 
Q30 and above (Figure 3.8). The cluster density for Run 2 was 495 k/mm2, and a total of 6.57 
Gb of data was obtained. Of the reads mapped to the indices used, 75.9 % passed the filter set 
by the on-board sequencing software, and 4.2 Gb (63.9%) had a quality score of Q30 and above 
(Figure 3.8).  
 
 
Figure 3.7. Fragment size distribution analysis of the pooled library on the Agilent 2100 Bioanalyzer 
using the HS DNA Kit. 
(A)Run 1 1:100 dilution of the pooled library is displayed in the electropherogram (B) Run 2 1:10 dilution of the 
pooled library is displayed in the electropherogram. 
 
 
 
 
A B 
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Figure 3.8. Q-Score Distribution Plot. 
(A)The percentage of bases with a quality score of Q30 and above was 64.9 % (3.7Gb) for Run1, and (B) 63.9 % 
(4.2Gb) for Run2.  
 
 
 
3.4.2.3. Bioinformatics Analysis 
 
A total of 14 921 435 reads were generated from the two sequencing runs. A median number 
of reads of 18 766 (IQR; 15 362 – 24 041) was obtained per sample. The number of reads 
decreased by 87.8% to 1 820 540, after the initial quality control steps that included merging, 
quality filtering, dereplication and removal of chimeras (Table 3.4) were performed. The 
sequencing reads decreased by another 6.9% after the removal of contaminants. The total 
number of reads thus used in the analysis for the two runs was 1 694 469 (Table 3.4). 
 
Table 3.4. The number of reads generated after the different quality control steps. 
Process Number of Reads 
After Sequencing 14 921 435 
Before contamination removal 1 820 540 
After contamination removal 1 694 469 
Used for Analysis 1 694 469 
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3.4.2.4. Rarefaction Curve 
 
The rarefaction curves of the infants at birth, 6 weeks and 12 months reached the plateau phase, 
indicating sufficient sequencing depth for measures of diversity. However, the rarefaction 
curves of the infants 6 month samples had insufficient sequencing depth (Figure 3.9). 
 
 
Figure 3.9. Rarefaction curves of all the samples sequenced via the V4 region of the 16S rRNA gene. 
 
3.4.2.5. The similarity between the aspirate stool and the passed stool (beta diversity) 
 
The aspirated samples and passed stool samples were similar to each other according to the 
mean beta diversities using . Table 3.5 shows the mean beta diversities at the different time 
points, from 6 weeks to 12 months. At all the time points the aspirated samples were very 
different when compared to the aspirated controls as represented by the high beta diversities 
(Table 3.5).  
 
Table 3.5. Mean beta diversities as calculated using . 
 6 weeks 6 months 12 months 
 Control AS PS Control AS PS Control AS PS 
Control 0.260 0.961 0.957 0.260 0.947 0.949 0.260 0.947 0.959 
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AS 0.961 0.627 0.631 0.947 0.650 0.666 0.947 0.621 0.670 
PS 0.957 0.631 0.571 0.949 0.666 0.678 0.959 0.670 0.615 
AS – Aspirated stool. PS – Passed stool. Control – spike (Cyanobacteria DNA) extracted and sequenced 
aspirate water blank. 
 
The mean beta diversities using  showed that the aspirated samples and passed stool 
samples were similar to each other. Table 3.6 shows the mean beta diversities using  at the 
different time points, from 6 weeks to 12 months. At all the time points the aspirated samples 
were very different when compared to the aspirated controls as shown by the high beta 
diversities (Table 3.6). In both cases, the pattern was similar for  and . As a result, for 
the downstream analysis, both aspirate and passed stool samples were included.   
We observed that the infant passed stools clustered together with the aspirated stools (Figure 
3.10).  The two sample types overlapped, showing that they cannot be differentiated. 
 
 
Table 3.6. Mean beta diversities as calculated using . 
 6 weeks 6 months 12 months 
 Control AS PS Control AS PS Control AS PS 
Control 0.151 0.955 0.930 0.151 0.913 0.910 0.151 0.918 0.932 
AS 0.955 0.331 0.376 0.913 0.488 0.518 0.918 0.462 0.482 
PS 0.930 0.376 0.418 0.910 0.518 0.530 0.932 0.482 0.442 
AS – Aspirated stool. PS – Passed stool. Control – spike (Cyanobacteria ) DNA extracted and sequenced 
aspirate water blank. 
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Figure 3.10. Multi-dimensional scaling (MDS) plots of the infant aspirated and passed stool at 6 months. 
Red – aspirated stool samples, blue – passed stool samples. 
 
 
3.4.3. Faecal bacterial profile 
3.4.3.1. Infant bacterial profiles in the first year of life (phylum level) 
 
 
Figure 3.11. Overall diversity plot for the infant samples. 
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The x-axis shows the covariates and age in days. The y-axis shows the diversity values. 
 
 
The overall diversity in the infant stool bacteria increased with age (Figure 3.11). 
Characterization of the stool bacteria of infants in this study shows that at the four time-points, 
there were distinct differences in the bacterial profiles (Figure 3.12). At birth, the phylum 
Proteobacteria (84.4%) was the most abundant in the infant stool samples (n=159), followed 
by the phyla Firmicutes (9.1%), Actinobacteria (6.4%) and Bacteroidetes (0.1%). At six weeks 
(n=114), the amount of Proteobacteria dropped to 28.9%, and the phylum Actinobacteria 
(44.7%) became the most abundant. The phylum Firmicutes more than doubled in abundance 
from birth to six weeks and continued to increase to 38.9% at 12 months. The phylum 
Bacteroidetes remained low over the 12-month period (Figure 3.12). Actinobacteria was low 
at birth and peaked at around 100 days and dropped to around 20% relative abundance at one 
year (Figure 3.13 A). Bacteroidetes remained the lowest from birth to 12 months (Figure 3.13 
B). Firmicutes were also low at birth and steadily rose till one year (Figure 3.13 C). 
Proteobacteria was the highest at birth and dropped to over 20% relative abundance at one 
year (Figure 3.13 D). Additional relative abundance plots from the faecal samples and controls 
included in this study are included in the Appendices A-B. 
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Figure 3.12. Phylum level bacterial profiles of the infant stool samples from birth to 12 months. 
The relative abundances of the bacterial phyla in the infant stool samples at different time points were visualized 
by bar plots. Each bar represents all the subjects at that time-point, and each coloured box a bacterial taxon.  
 
 
Figure 3.13. Relative abundance plots for the infants at phylum level from birth to 12 months. 
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(A) Actinobacteria (B) Bacteroidetes (C) Firmicutes (D) Proteobacteria. The x-axis shows the age in days and 
the y-axis shows the relative abundance of the bacteria. The red line is a plot of a model that was fitted in which 
age was significant. 
 
 
3.4.3.2. Infant bacterial profiles in the first year of life (genus level) 
 
At birth, the genus Acinetobacter (76.7%) dominated the infant stool bacteria, with the 
remaining genera having relative abundances below 10% (Figure 3.14). At the six weeks, six 
months and 12 month time points, the most abundant genus was Bifidobacterium at 55.3%, 
55.6% and 41.2% respectively (Appendix B, Figure S8). Escherichia-Shigella, Streptococcus, 
Acinetobacter and Blautia were the following genera with the high relative abundances at all 
three time-points. At 12 months, Bifidobacterium (41.2%) was the most abundant genus, 
followed by Acinetobacter (16.2%), Blautia (9.9%), Escherichia-Shigella (9.2%) and Incertae 
Sedis (5.5%) (Figure 3.14). Bifidobacterium was low at birth and peaked at around 100 days, 
and dropped again at one year (Appendix B, Figure S8C). Clostridium remained very low from 
birth to 12 months (Appendix B, Figure S8E). Faecalibacterium was also very low at birth and 
steadily rose till one year (Appendix B, Figure S8I). Lactobacillus was low at birth, peaked 
around 6 week and dropped at one year (Appendix B, Figure S8K). 
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Figure 3.14. Genus level bacterial profiles of the infant stool samples from birth to 12 months. 
The relative abundances of the bacterial genera in the infant stool samples at different time points were visualized 
by bar plots. Each bar represents all the subjects at that time-point, and each coloured box a bacterial taxon. 
 
 
3.4.4. External factors contributing towards the composition of the infant gut bacterial 
profile 
 
3.4.4.1. The effect of breastfeeding on the infant stool bacterial profile 
 
Breastfed infants were defined as infants who did not receive formula at any of the time points, 
while formula-fed infants were defined as infants who received formula only. In this study, five 
main bacterial taxa were shown to be affected by breastfeeding, with only two of them being 
significant. The phylum Actinobacteria was found in significantly higher amounts for infants 
that were breastfed in the first year of life (p= 8.569442e-05) (Figure 3.15 A). The phylum 
Proteobacteria was also found in significantly lower amounts for breastfed infants (p= 
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3.480703e-02) (Figure 3.15 E). The phylum Bacteroidetes was found in higher amounts at the 
age of 12 months in infants that were not breastfed, though this was not significant (Figure 3.15 
B). The genus Bifidobacterium was found in larger amounts for breastfed infants, while 
Firmicutes were in lower proportions (Figure 3.20 C, D).
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Figure 3.15. Bacterial Taxa affected by breastfeeding. (A) Actinobacteria (B) Bacteroidetes (C) Bifidobacterium (D) Firmicutes (E) Proteobacteria. The x-axis shows the 
age in days and the y-axis shows the relative abundance of the bacteria. The bottom left – infants with no breastfeeding data recorded, bottom right –formula fed, top left – 
breastfed, top right – taxa at birth for breastfed infants.  The red line is a scatterplot smoother indicating the trend in that subset.
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3.4.4.2. The effect of the use of electricity on the infant stool bacterial profile 
 
Only three taxa were affected by electricity as the primary cooking source in this study. At 
birth, Proteobacteria was significantly lower in infants from homes that used electricity as 
energy sources for cooking (p= 3.525485e-04) (additional data which not shown). 
Actinobacteria was significantly increased (p= 8.130155e-09), in infants where electricity was 
the main cooking source, especially at six weeks of age (Figure 3.16 A). Bifidobacterium was 
increased in infants, especially at six weeks of age where electricity was the main cooking 
source, though this was not significant (Figure 3.21 B). At 12 months of age, the proportion of 
Actinobacteria, Bifidobacterium and Proteobacteria in infants whose households used 
electricity was similar to those that did not.  
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Figure 3.16. Bacterial Taxa affected by main cooking fuel (electricity) in the household. (A) Actinobacteria 
(B) Bifidobacterium (C) Proteobacteria. The x-axis shows the age in days and the y-axis shows the relative 
abundance of the bacteria. The left – electricity, right – other fuels. The red line is a scatterplot smoother 
indicating the trend in that subset. 
 
3.4.4.3. Additional factors affecting the infant stool bacterial profile 
 
Infants not exposed to cats had significantly higher proportions of Proteobacteria primarily 
between the ages six and 12 months (p= 0.01229328) (Figure 3.17 A). At six and 12 months, 
infants not exposed to dogs had significantly lower Proteobacteria in their stool (p= 
0.001300965) (Figure 3.17 B). Infants that stayed in homes with four to eight household 
members had significantly higher amounts of Proteobacteria in their stool throughout the first 
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year of life (p= 0.02571465) (Figure 3.17 C). Household members were defined as other people 
who stayed in the house besides the mother, these included siblings and other adults. However, 
at 12 months of age infants with older siblings had decreased amounts of Proteobacteria in 
their stool, though this decrease was not significant (Figure 3.17 D). The effect of having other 
household members as well as older siblings was also analysed separately, since siblings are 
usually in closer contact with infants, and are likely to influence their bacterial profile in early 
years. The increase in the amount of Firmicutes was significantly pronounced in rural areas 
(p= 0.01690662), in comparison to urban areas and townships (Figure 3.17 E). 
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Figure 3.17. Risk factors that affect the proportions of bacterial members of the infant stool bacteria. 
The x-axis shows the age in days and the y-axis shows the relative abundance of the bacteria. (A) Cats and 
Proteobacteria. The bottom left – exposed to 0 cats, bottom right – exposed to 0-2 cats, top left – exposed to 2-6 
cats. (B) Dogs and Proteobacteria. The bottom left – exposed to 0 dogs, bottom right – exposed to 0-2 dogs, top 
left – exposed to 2-6 dogs. (C) Household members and Proteobacteria. The bottom left – exposed to no 
household members, bottom right – exposed to 4-8 household members, top left – exposed to 8-20 household 
members. (D) Total number of children mother has and Proteobacteria. The bottom left – exposed to 0 siblings, 
bottom right – exposed to 0-2 siblings, top left – exposed to 2-5 siblings. (E) Living area and Firmicutes. The 
bottom left – living area type unknown, bottom right – rural living area, top left – township living area, top right 
– urban living area. The red line is a scatterplot smoother indicating the trend in that subset. 
 
3.4.4.4. Factors affecting the infant stool diversity 
 
Three main risk factors were found to significantly affect the diversity of the infant stool 
bacteria. Infants with older mothers had higher diversity in their stool (p= 0.0073) (Figure 3.18 
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A). Diversity in the infant stool samples also increased with age, but this progression was 
slower in babies that were shorter at birth (birth length < 40cm), (p= 0.00018) (Figure 3.18 B). 
For infants aged six months and under, diversity decreased as birth weight increased (p= 
0.032). However, at 12 months the opposite is true (Figure 3.18 C).  
 
 
Figure 3.18. Risk factors affecting the diversity of the infant stool bacteria. 
(A) Maternal age. The x-axis shows the maternal age and the y-axis shows the diversity. The bottom left – birth 
(infant), bottom right – 6 weeks (infant), top left – 6 months (infant), top right – 12 months (infant). (B) Birth 
length. The x-axis shows the age in days and the y-axis shows the diversity. The bottom left – 30-40cm, bottom 
right – 40-45cm, top left – 45-50cm, top right – 50-60cm. (C) Birth weight. The x-axis shows the age in days and 
the y-axis shows the diversity. The bottom left - birth, bottom right – 6 weeks, top left – 6 months, top right – 12 
months. The red line is a scatterplot smoother indicating the trend in that subset. 
 
3.4.5. Infant wheezing in the first year of life 
 
3.4.5.1. The effect of wheezing on the composition of infant stool bacteria 
 
Log ratio biplots of the infant stool samples (both aspirate and passed stools), based on 
wheezing status from birth to 12 months did not appear to form any distinct clusters both at 
phylum and genus level (Figures 3.19 and 3.20). In the first year of life, the infants stool 
bacterial profiles at phylum level did not cluster according to the different wheezing outcomes 
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
0 100 200 300 400
0 100 200 300 400
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
age.days
div
.va
ls
30 35 40 45 50 55 60
Given : birth.len
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
20 25 30 35 40 45
20 25 30 35 40 45
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
M.age
div
.va
ls
birth
6 weeks
6 months
12 months
Given : age
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
1.0 1.5 2.0 2.5 3.0 3.5 4.0
1.0 1.5 2.0 2.5 3.0 3.5 4.0
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
birth.wt
div
.va
ls
birth
6 weeks
6 months
12 months
Given : age
A B 
C 
  79 
(Figure 3.19). At genus level from birth to one year, the infant stool bacterial profiles were also 
randomly dispersed in relation to the wheezing outcome (Figure 3.20). 
 
 
Figure 3.19. Log ratio biplots of infant stool samples at phylum level in relation to wheezing sampled at 
birth, six weeks, six months and 12 months. 
Stool samples of infants that did not wheeze are shown in green, those that wheezed once in gold and those that 
wheezed twice, or more are shown in red.  
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Figure 3.20. Log ratio biplots of the infant stool samples at genus level in relation to wheezing sampled at 
birth, six weeks, six months and 12 months. 
Stool samples of infants that did not wheeze are shown in green, those that wheezed once in gold and those that 
wheezed twice or more are shown in red.  
 
3.4.5.2. The association between wheezing and infant bacteria 
 
The proportions of the Lactobacillales in infants who wheezed recurrently during the first year 
of life was more than those who wheezed once during the same period. Infants who wheezed 
once, with an onset of about seven days, had no change in the proportion of Lactobacillales 
from birth to 12 months of age (Figure 3.21). On the other hand, infants who wheezed 
recurrently, with the same onset of seven days had increased proportions of Lactobacillales 
from birth to 12 months (Figure 3.21). Infants with a wheezing onset of both 140 and about 
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210 days, did not have differences in proportions of Lactobacillales between those that 
wheezed once and those that wheezed recurrently (Figure 3.21). Infants who wheezed two or 
more times in the first year of life had significantly higher proportions of Lactobacillales 
present in their stool (p=0.04083). The proportion of Proteobacteria decreased from birth to 
12 months in infants that did not wheeze (Figure 3.22). The amount of Proteobacteria 
increased at 12 months if the infants had wheezed before (Figure 3.22).  
 
 
 
Figure 3.21. Coplot of bacteria at order level and wheezing variables (Lactobacillales).  
The x-axis represents the age of infants in days. The y-axis represents the relative abundance of the 
Lactobacillales present in the infant samples. The three vertical panels represent the different wheezing 
outcomes; 0 wheeze, 1 wheeze, ≥2 wheeze episodes. The four horizontal panels represent the four wheezing 
onset groups; zero to 40 days, 41 to 130 days, 131 to 224 days, 225 to 365 days. The red line is a scatterplot 
smoother indicating the trend in that subset. 
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Figure 3.22. Coplot of bacteria at phylum level and wheezing variables (Proteobacteria). 
The x-axis represents the age of infants in days. The y-axis represents the relative abundance of the Proteobacteria 
present in the infant samples. The bottom left – 0 wheezing episodes, bottom right –  wheezing episode, top left 
– 2-4 wheezing episodes. The red line is a scatterplot smoother indicating the trend in that subset. 
 
 
 
 
3.5. Discussion 
 
The principal aim of the study was to investigate the association between the stool bacteria and 
the development of recurrent wheezing in infants. In this study, the composition of certain stool 
bacteria was associated with the development of wheezing illness. The log-ratio biplots of the 
overall bacterial profiles, generated for the wheezing outcome in this study did not show any 
distinct clusters. This means that infants with different wheezing outcomes did not have 
significant differences within their stool bacterial profiles, to group separately. Thus, the 
overall infant bacterial profiles were fairly similar between the two wheezing outcomes; infants 
that wheezed once and infants that wheezed two or more times in the first year of life. However, 
upon generation of the coplots, one bacterial taxon (Lactobacillales) was seemingly 
significantly associated with the development of wheezing though there were no clear 
differences in children with late wheeze onset. A study by Amberbir and colleagues reported 
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that the presence of Lactobacillus was not associated with increased risk of allergic symptoms 
such as wheezing, which is contrary to the results found in our study (Amberbir et al., 2011). 
A study by Penders and colleagues also reported that colonization by Lactobacillus was not 
associated with atopic manifestations, including wheezing (Penders et al., 2007). Penders and 
colleagues also concluded that development of recurrent wheeze was associated with 
colonization by C. difficile in early infancy (Penders et al., 2007). A more recent study by Salas 
and colleagues observed that at one year of age wheezing infants had over-representations of 
the Lachnospiraceae, Rikenellaceae and Ruminococcaceae families (Salas et al., 2014). This 
is different to what was found in the Canadian studies, as they reported the reduction in 
proportion of the FLVR bacteria in wheezing infants at three months of age, and much less 
apparent differences at one year (Arrieta et al., 2015). Salas and colleagues also reported that 
infants with two or more wheezing episodes had under-represented amounts of the Clostridium 
genus (Salas et al., 2014). More recent studies have investigated the combined contribution of 
both the bacterial and the fungal components of the stool in the development of wheezing and 
asthma later on in life (Arrieta et al., 2017; Fujimura et al., 2017). Another study by Arrieta 
and colleagues carried out in rural Ecuador identified different bacterial and fungal groups 
responsible for the development of wheezing in infants (Arrieta et al., 2017). Ecuadorian 
infants with increased proportions of Streptococcus and Bacteroides species and reduced 
Bifidobacterium and Ruminococcus gnavus developed wheezing later on in infancy (Arrieta et 
al., 2017). The wheezing infants from the Ecuador study also had reduced Saccharomycetales 
and increased Pichia kudriavzevii in their three month stools (Arrieta et al., 2017). Arrieta and 
colleagues were able to demonstrate the importance of the fungal component in the 
development of infant wheezing in this Ecuadorian cohort (Arrieta et al., 2017). The vast 
differences between the results of the two studies by Arrieta and colleagues in Canada and 
Ecuador bring forth the idea that different bacterial and fungal species are responsible for the 
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development of wheezing in different regions of the world. In spite of this information 
obtained, we suspect that the observed differences between the proportions of Lactobacillales 
in infants who wheezed and those who did not were due to outliers and few data points for 
recurrent wheezers. We assume that more infants that have wheezed recurrently would need to 
be included to increase the statistical strength of the results for this particular objective.   
 
To our knowledge, no infant bacterial studies have been carried out using both aspirated and 
passed stool. Patel and colleagues are one of the groups that used gastric aspirates as the sample 
of choice for 16S rRNA-based Denaturing Gradient Gel Electrophoresis, but did not use passed 
stool samples or measure the difference if any (Patel et al., 2015). For this study, mean beta 
diversities were measured using Whittaker (  and Simpson’s  formulas, and similar 
patterns were observed for the aspirated and passed stool samples (Simpson, 1943; Whittaker, 
1960). Aspirated stool samples were observed to be similar to passed stool samples, because 
of the clustering of the two sample types in the multidimensional scaling plots. Statistically 
significant differences between aspirated and passed stool samples were due to concentration 
differences. The purity of the passed stool samples in this study was significantly higher than 
that of the aspirated stool samples. The lower purity values in the aspirate samples indicate the 
presence of contaminants like phenols and proteins that would skew this value (Thermo 
Scientific). In longitudinal studies, passed stool can sometimes be difficult to obtain at specific 
time points, especially in infants. Given that aspirated stool can be collected at any time, this 
makes this sample type favourable for stool bacterial studies going forward. This study was 
able to confirm that the use of aspirate stool samples is sufficient for use in 16S rRNA 
sequencing analysis. Therefore, aspirated stool samples can be used in gastrointestinal 
microbiome studies with confidence that the results will be representative of passed stool.  
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In this study, the bacterial profile at six months was dominated by the phylum Actinobacteria, 
followed by Firmicutes, Proteobacteria and Bacteroidetes. A study by Thompson and 
colleagues showed a similar profile, except that their infants had a higher proportion of 
Bacteroidetes than Proteobacteria (Thompson et al., 2015). Another study reported a six 
month infant bacterial profile that was dominated by Firmicutes, followed by Actinobacteria 
and Bacteroidetes (González et al., 2013). A study by Azad and colleagues, which had infants 
that were sampled at four months of age supported the observations made in this study, though 
the proportions were slightly different (Azad et al., 2013). This study as well as the study by 
Azad and colleagues had a similar objective; the effect of risk factors such as presence of 
siblings and pets on the infant stool composition (Azad et al., 2013).  
 
The overall diversity of the infant stool bacteria in this study increased over time, as is reported 
by other researchers (Konya et al., 2014; Arrieta et al., 2015; Azad et al., 2015, 2016; Bäckhed 
et al., 2015). This increase in diversity was expected, because as infants grow they are exposed 
to more sources of bacteria (Frese and Mills, 2015). In this study, the infant stool diversity was 
positively affected by formula feeding. Previous studies addressing feeding methods in infants, 
have reported conflicting results. Some studies have shown formula fed infants to have higher 
diversity (Thompson et al., 2015), while other studies have shown breastfed infants to have 
higher diversity (Gewolb, Schwalbe and Taciak, 1999). The data gathered from this study, as 
well as other studies confirms that different feeding methods cause increase in the infant stool 
diversity, though the overall profiles might differ. 
 
Diet or feeding method has been shown to influence the infant stool bacterial profile during the 
first year of life (Palmer et al., 2007; Madan et al., 2012; Yatsunenko et al., 2012; Groer et al., 
2014). Breastfed infants in this cohort had decreased amounts of Firmicutes and 
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Proteobacteria and increased proportions of Actinobacteria, specifically Bifidobacterium. This 
profile is similar to that of the breast milk, which is lower in Proteobacteria and higher in the 
phyla Actinobacteria, suggesting that certain bacterial taxa are acquired through this feeding 
method (Penders et al., 2006; Palmer et al., 2007; Turroni et al., 2012; Di Mauro et al., 2013; 
Torrazza and Josef, 2013). The infants that were formula fed were found to have increased 
proportions of the phylum Bacteroidetes (Penders et al., 2006; Adlerberth and Wold, 2009). 
The differences observed between breastfed and formula fed infants supports the notion that 
the feeding method significantly affects or alters the infant stool composition.  
 
Crowding entails any of the following: attendance at a daycare centre, presence of siblings or 
a large number of household members. In this study, infants in homes with more than five 
household members had higher amounts of Proteobacteria in their stool throughout the first 
year of life. A study focusing on the respiratory microbiome supports the increase in the 
phylum Proteobacteria in infants exposed to crowding via daycare centres and presence of 
older siblings (Bosch et al., 2017). Similarly, in this study, infants with siblings also exhibited 
higher amounts of Proteobacteria compared to those without. The presence of older siblings 
has been associated with a reduced risk of developing atopic diseases, including asthma and 
food allergy (Strachan, 1989; Koplin et al., 2012). Previous studies investigating the 
association between having older siblings and the infant gut bacterial profile have mostly 
observed increased amounts of the phyla Firmicutes and Actinobacteria. This profile was 
represented by the increased proportions of Bifidobacteria and Staphylococcus aureus, in 
conjunction with delayed colonization of the taxon Clostridium (Penders et al., 2006; 
Adlerberth et al., 2007; Lindberg et al., 2011). In this study, the presence of siblings was not 
associated with increased amounts of the phyla Firmicutes and Actinobacteria as found in other 
studies. 
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Exposure of infants to pets has been associated with a reduced risk of developing atopic 
diseases, including asthma and food allergy (Strachan, 1989; Hesselmar et al., 1999; Koplin et 
al., 2012). Infants in this study exposed to cats had significantly lower proportions of the 
phylum Proteobacteria from six to 12 months when compared to unexposed infants. Whereas 
infants in this study exposed to dogs had higher proportions of the phylum Proteobacteria. 
Nermes and colleagues observed differences in the proportions of Bifidobacterium species in 
pet exposed and non-exposed infants (Nermes et al., 2013). Tun and colleagues reported 
increased richness of the phylum Firmicutes in the stool of pet exposed infants (Tun et al., 
2017). From the results of this current study and others by different research groups it can be 
noted that pet exposure affects different bacterial groups. This study showed a significant 
increase in the phylum Firmicutes in infants living in rural areas. Similarly, other studies have 
observed gut bacteria dominated by Firmicutes in individuals from rural areas (Tyakht et al., 
2013; Martinez et al., 2015). In contrast, De Filippo and colleagues found a depletion of 
Firmicutes in children from rural areas in Burkina Faso (De Filippo et al., 2010).  
 
 
3.6. Conclusion 
 
Aspirate and passed stool samples were found to be very similar and indistinguishable. There 
were no differences in the overall stool bacterial profiles of the infants with the different 
wheezing outcomes. Recurrent wheezing was significantly associated with the composition of 
Lactobacillales, though this association was due to outliers and few data points. Some of the 
limitations of this study included inadequate number of recurrent wheezers, incomplete clinical 
data due to poor collection and incomplete sample collection for infants. We envisage that a 
more extensive sample size is required to be able to obtain statistically significant results.  
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3.8. Appendix 
 
 
 
Appendix A 
  
Figure S1. Genus level bacterial profiles of the of the aspirate controls in this study. The relative abundances 
of the bacterial genera in the aspirate controls were visualized by bar plots. Each bar on the x-axis represents an 
aspirate control, and each coloured box a bacterial taxon. The y-axis represents the proportions of the bacterial 
groups in the controls. 
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Appendix B 
Infant Class Profiles over time 
 
 
Figure S2. Relative abundance plots for the infants at class level from birth to 12 months. (A) Actinobacteria (B) Bacilli (C) Bacteroidia (D) Clostridia (E) 
Gammaproteobacteria. 
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Figure S3. Class level bacterial profiles of the infant stool samples from birth to 12 months. The relative 
abundances of the bacterial phyla in the infant stool samples at different time points were visualized by bar plots. 
Each bar represents all the subjects at that time-point, and each coloured box a bacterial taxon.  
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Infant Order profiles over time 
 
Figure S4. Relative abundance plots for the infants at order level from birth to 12 months. (A) Bacteroidales (B) Bifidobacteriales (C) Clostridiales (D) Enterobacteriales 
(E) Lactobacillales (F) Pseudomonadales. 
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Figure S5. Order level bacterial profiles of the infant stool samples from birth to 12 months. The relative 
abundances of the bacterial orders in the infant stool samples at different time points were visualized by bar plots. 
Each bar represents all the subjects at that time-point, and each coloured box a bacterial taxon.  
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Infant Family profiles over time 
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Figure S6. Relative abundance plots for the infants at phylum level from birth to 12 months. (A) Bacteroidaceae (B) Bifidobacteriaceae (C) Clostridiaceae (D) 
Enterobacteriaceae (E) Enterococcaceae (F) Lachnospiraceae (G) Lactobacillaceae (H) Moraxellaceae (I) Prevotellaceae (J) Pseudomonadaceae (K) Ruminococcaceae 
(L) Streptococcaceae (M) Veillonellacea.
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Figure S7. Family level bacterial profiles of the infant stool samples from birth to 12 months. The relative 
abundances of the bacterial families in the infant stool samples at different time points were visualized by bar 
plots. Each bar represents all the subjects at that time-point, and each coloured box a bacterial taxon. 
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Figure S8. Relative abundance plots for the infants at genus level from birth to 12 months. 
(A) Acinetobacter (B) Bacteroides (C) Bifidobacterium (D) Blautia (E) Clostridium (F) Dorea (G) Enterococcus (H) Escherichia-Shigella (I) Faecalibacterium (J) Incertae 
Sedis (K) Lactobacillus (L) OTU 31 (M) Prevotella (N) Pseudobutyrivibrio (O) Pseudomonas (P) Streptococcus. 
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Chapter 4 - General Discussion 
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4.1. Discussion 
 
 
The aims of this Masters’ dissertation were to use next generation sequencing technology to 
describe the major components of the infant gut bacterial profile in the first year of life, identify 
major risk factors that influenced this composition and investigate the association between the 
gut bacteria and the development of recurrent wheezing in infants. This study was carried 
within the Drakenstein Child Health Study, which is a prospective birth cohort from a low 
socio-economic community that is found in the Western Cape of South Africa.  
 
To the best of our knowledge, this is the first study to use two different stool sampling 
techniques, namely passed stool and aspirated stool, in infants for 16S rRNA sequencing. 
Aspirated stool was considered as a stool sampling option for infants, due to the difficulty 
experienced when trying to collect the sample on a specific day. The results from the initial 
statistical analysis showed that aspirated and passed stool samples were indistinguishable, 
hence proving the high level of similarity. This demonstrated that aspirated samples were good 
enough as an alternative for passed stool samples. Other studies have investigated the use of 
rectal swabs as an alternative to passed stool, and have observed minimal profile differences 
between the two sampling techniques (Sinha et al., 2016; Bassis et al., 2017). The profiling of 
the infant gut bacteria in the first year of life showed that this community is very dynamic and 
over time starts to mimic the adult gut bacterial profile. Previous studies that have investigated 
the adult gut bacterial profile have observed that this profile is distinctly different from the 
infant profile as it is generally stable, and has minimal fluctuations over time (Yatsunenko et 
al., 2012; Rodríguez et al., 2015). On the other hand, the gut bacterial profiles of infants exhibit 
high inter-individual diversity during the first few year of life (Yatsunenko et al., 2012).  
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From this study, infants that were breastfed in the first year of life had significant differences 
in some bacterial taxa when compared to those who were not. There was no association 
between breast feeding and development of wheezing in this study. Formula fed infants in this 
study had increased proportions of Bacteroidetes and this has been shown in other studies 
(Penders et al., 2006; Adlerberth and Wold, 2009). Other studies showed that exclusively 
breastfed infants had a higher composition of Bifidobacteria, and lower compositions of E. coli 
and C. difficile (Nambu, Shintaku and Ohta, 2004; Penders et al., 2008). These studies found 
inconsistent data on the association between the mode of feeding and the development of 
wheezing illness in infants. A major limitation of this study was that the sequencing carried out 
was only able to characterize the bacteria up to genus level. This limited the level to which we 
were able to determine association between the infant stool bacteria and wheezing illness. 
Performing Whole Genome Shotgun sequencing on the Illumina platform would allow 
identification down to species level taxonomy (Ma, Prince and Aagaard, 2014). 
 
The use of electricity as a primary fuel affected the infant bacterial composition but was not 
associated with wheezing in the first year of life. The taxa Actinobacteria and Bifidobacterium 
were significantly increased and Proteobacteria was significantly reduced in infant’s stool 
whose households used electricity. We presume that the socioeconomic status which is 
represented by the use of electricity plays a role in influencing the gut bacterial composition. 
Previous studies by groups in different countries have shown that the socioeconomic status 
affects the gut bacterial composition (Tyakht et al., 2013; Chong et al., 2015; Mello et al., 
2016; Miller et al., 2016). Studies in literature have also reported that the socioeconomic status 
affects the state of allergy, including wheezing and/or asthma in children (Forastiere et al., 
1997; Hafkamp-de Groen et al., 2012; Galobardes et al., 2015). 
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Most studies suggest that pet exposure has a protective effect on the development of allergic 
diseases including wheezing illness (Azad et al., 2013; Nermes et al., 2013; Tun et al., 2017). 
However, we were unable to establish a relationship between pet exposure and the development 
of wheezing illness. Few studies from the systematic review investigated the direct or indirect 
involvement of pets in the development of wheezing illness (Murray et al., 2005; Penders et 
al., 2007, 2008; van Nimwegen et al., 2011; Arrieta et al., 2015; Stiemsma et al., 2016). Only 
one of the studies included in the systematic review observed an association between pet 
ownership and development of wheeze and atopic sensitization (Murray et al., 2005). 
 
Previous studies investigating crowding have reported conflicting information on the 
association with the gut microbiota and wheezing (Infante-Rivard et al., 2001; Rusconi et al., 
2005; Nicolaou et al., 2008; Luijk et al., 2015). In this study, there was no association between 
infants that experienced crowding either by having multiple siblings or by being in homes with 
large numbers of household members and the development of wheezing. However, differences 
were observed in the gut microbiota of infants who were exposed to crowding, versus those 
who were not. More studies investigating different crowding variables in association with 
development of wheezing in infancy would be beneficial in tackling this topic more 
exhaustively. 
 
In this study, the living area had an effect on the infant stool bacteria but was not associated 
with the development of wheezing in infants. Infants living in rural areas had increased 
amounts of Firmicutes, when compared to those living in urban areas and townships. This is 
possibly due to the fact that diets higher in starch, consumed in rural communities tend to be 
associated with gut bacterial populations dominated by Firmicutes (Liefert, 2004; Flint et al., 
2012). Nevertheless other studies have found that children growing up in farm or rural areas 
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were less likely to experience wheezing (Riedler et al., 2000; Von Ehrenstein et al., 2000; Stein 
et al., 2016). 
 
Additionally, we were able to observe a relationship between the infant gut bacterial profile 
and wheezing illness, as shown by other studies (Murray et al., 2005; van Nimwegen et al., 
2011; Arrieta et al., 2015; Stiemsma et al., 2016). From the bi-plots only one bacterial taxon 
(Lactobacillales) was significantly associated with wheezing, although we suspect that this was 
due to outliers and few data points for recurrent wheezers. Previous studies have shown that 
wheezing was associated with various bacterial taxa including Bifidobacteria, Clostridia and 
the FLVR (Faecalibacterium, Lachnospira, Vellionella and Rothia) bacteria (Verhulst et al., 
2008; Arrieta et al., 2015; Stiemsma et al., 2016). We assume that increasing the number of 
recurrent wheezers would show a stronger association to certain bacterial taxa.  
 
This study had limitations which affected the data analyzed herein. One of these limitations 
was that the majority of infants did not have full data sets, they often had one or more missing 
samples, and this prevented the wheezing analysis from being carried out exhaustively. 
Another limitation was the incomplete clinical data profiles collected for the participants, 
which accounted for about 25%. This in turn hindered accurate analyses being carried out. 
Therefore it is important to have all the stool samples because other studies have observed that 
the first 100 days represent the critical period in which changes in the stool microbiota could 
be attributed to wheezing later on (Van Der Velden et al., 2001; Arrieta et al., 2015a; Stiemsma 
et al., 2016). 
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Chapter 5 - General Conclusion 
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5.1. Conclusion 
 
 
This study was able to profile the stool bacteria of the infants from birth to 12 months. In 
addition, we identified the risk factors that influenced the acquisition of specific bacterial 
groups or affected the stool diversity as a whole. This study was not able to conclusively 
determine any association between the infant wheezing and gut bacterial profile. We suspect 
that this was due to the inadequate number of recurrent wheezers within the first year of infant 
life.  
 
We anticipate that future studies on recurrent wheezing in this cohort would require a much 
larger group of recurrent wheezers, with full data sets on risk factors, clinical data and all the 
required samples collected. A larger recurrent wheezing cohort would enable researchers to 
note if the four bacterial genera; Faecalibacterium, Lachnospira, Vellionella and Rothia also 
had a protective role in infants in South Africa (Arrieta et al., 2015b; Stiemsma et al., 2016). 
Further research will also be required to assess the association of C. difficile colonization on 
the increased risk of wheezing in infants. As found in Systematic Review, more research needs 
to be carried out to determine the influence of prebiotics, probiotics and breastfeeding in the 
development of wheezing in infants. Similarly, since recurrent wheezing is one of the 
precursors of asthma, there is a need for an additional follow-up of the wheezing infants in 
order to investigate the contribution of the early faecal microbiome in the development of 
asthma at school age. 
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